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Abstract 
Currently there is an obvious demand for alternative transportation fuels to fulfill the requirements for 
the future transportation. Fatty acid ethyl esters (FAEEs) have chemical properties that are comparable 
with crude diesel or the currently available FAME biodiesels, but can be produced in a more 
sustainable way, based on microbial cell factories. During this PhD project, three different metabolic 
engineering strategies were applied to improve the production of FAEEs in Saccharomyces cerevisiae. 
In the first strategy the native cytosolic pyruvate dehydrogenase bypass was improved together with 
regulation of the acetaldehyde branch point, at which carbon can be converted into ethanol or into 
acetate and further to acetyl-CoA. Therefore, genes ADH2, ALD6 and acsSEL641P from Salmonella 
enterica, containing a point mutation to prevent acetylation in combination with a wax ester synthase 
(ws2) from Marinobacter hydrocarbonoclasticus were overexpressed on 2-micron plasmids which 
resulted in an 2.7 fold (p-value: 0.03) improved yield of 359 ± 128 μg FAEEs gCDW−1.  
A second metabolic engineering strategy was performed to re-channel the carbon flow via the pentose 
phosphate pathway and the heterologous phosphoketolase (PHK) pathway towards acetate and acetyl-
CoA and yield NADPH, needed for fatty acid synthase, as a byproduct. The first reaction of the two 
step PHK pathway is catalyzed by xylulose-5-phosphate phosphoketolase (encoded by xpkA from 
Aspergillus nidulans) and the second step is catalyzed by acetate kinase (encoded by ack from A. 
nidulans) or phosphotransacetylase (encoded by pta from Bacillus subtillis). The combined expression 
of xpkA and pta on a 2-micron plasmids resulted in  a FAEE yield of 105 ± 30 μg gCDW−1 which was 
an 5.7 fold (p-value: 0.03) improvement. Additional expression of xpkA and pta in a strain with 6 
integrated copies of ws2 resulted in 4670 ± 379 μg gCDW−1 (p-value: 0.02), a 1.6 fold higher FAEE 
yield than a reference, whereas the expression of xpkA and ack in the same background strain 
improved the yield to 5100 ± 509 μg FAEEs gCDW−1 (p-value: 0.01), which was a 1.7 fold 
improvement. 
The combined overexpression of ws2, ADH2, ALD6, acsSEL641P, ACC1S1157A,S659A (acetyl-CoA 
carboxylase with point mutations to prevent phosphorylation) and ACB1(acyl-CoA binding protein), 
which were stably integrated into the chromosome, was investigated together with the disruption of 
acyl-CoA competing pathways towards the formation of triacylglyceride (dga1Δ lro1Δ), sterol esters 
(are1Δ are2Δ) and acetyl-CoA (pox1Δ) and resulted in a yield of 1072 ± 160 μg total FAEEs gCDW-1 
(titer of 4.4 ± 0.7 mg l-1), which was a 4.1 fold improvement compared to sole ws2 expression. 
Transciptional analysis was performed on FAEE producing mutants of S. cerevisiae which pointed out 
the increased cellular stress that influenced cellular growth and the increased demand of cofactor 
NADPH which is therefore considered an engineering target for the future. 
Keywords: fatty acid ethyl ester, metabolic engineering, Saccharomyces cerevisiae, phosphoketolase 
pathway, transcriptome analysis, physiological characterization, genome integration. 
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1. Introduction 
1.1. Necessity of biofuels 
Motorized transport is a social-economic necessity which consequently creates a gigantic 
market for liquid fuels. World leading institutions like ‘The International Energy Agency 
(IEA, U.S.) and committees from the European Union (EU) frequently publish reports on 
changes and future developments in the transport fuel market [1-3]. Independent of the exact 
size of the future liquid fuel market, it is clear that transportation fuels take an increasing 
share of the total energy demand. It has been reported that the energy consumption by the 
transportation sector has increased by more than 20% to 65% of all fuel produced, during the 
last 35 years [2]. The diesel engine and the gas turbine are the driving forces for almost all 
transportation modes. Diesel fuel production is the largest in volume and provides marine 
engines (150 million metric tons per year, low quality) and large parts of road traffic (650 
million metric tons per year, high quality); whereas gasoline plays a role for lighter road 
vehicles and kerosene is used for aviation (190 million metric tons per year, high quality). 
The increase in energy demand can be mainly attributed to road transport which consumes 
about 75% of total transport energy and is largely driven by diesel fuel [4]. Predictions, based 
on this increase in energy consumption for transport modes, foresee a further energy increase 
of 50% until 2030 and an 80% increase in energy consumption until 2050. Additionally it is 
believed that the traditional petroleum based fuel consumption will decrease with 50% in 
2050 and be replaced by alternative fuels [1]. Concomitantly, the biofuel share is expected to 
increase 10-fold between 2010 and 2050 (>30 Exajoules) (Figure 1.1) [2, 5] and therefore, 
there is an obvious demand for alternative transportation fuels, like biodiesel.  
 
Figure 1.1: One assumption of the changing and growing biofuel market with the number above the chart 
representing the year and number underneath the total amount of energy in the biofuel market. 
 
Nowadays, energy for transport is heavily leaning on the support from fossil fuels. However, 
the use of fossil fuels faces a number of challenges, among which the risk of depletion. 
Several predictions assumed that the so-called ‘peak-oil’ was reached around 2011. This 
means that the consumption of oil became larger than the production of it [5]. While 
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discussions about the size of fossil fuel reserves and the necessity of alternatives remain 
active [6], it is broadly accepted, that an increased energy demand will result in fossil oil 
scarceness. This will consequently lead to higher energy friction, at the economic, political 
and environmental level and requires measures to be taken to provide a new and more 
sustainable source of energy. In parallel to new technological developments in the transport 
sector, biofuels and especially biodiesels, which has the largest energy density per volume 
and per weight [1, 2], will play an important role in fossil fuel replacement and therewith part 
of a more sustainable future. 
1.2. History and maturation of biodiesel and other biofuels 
The concept of biofuels is as old as the invention of the car engine itself. The first cars ever 
built were made to function on biofuels, rather than fossil fuels. In such a way, the first 
internal combustion engine to be patented in 1826 was designed to run on a blend of ethanol 
and turpentine (derived from pine trees). Henry Ford expected his Ford T to run on ethanol 
and in 1900 Rudolph Diesel demonstrated his peanut oil powered diesel engine during the 
world exhibition in Paris. Despite the early attempts of liquid biofuel powered transport, the 
use of fossil fuels was widely implemented due to the sudden large crude oil availability, the 
low price, the high efficiency and practicality at this time. These advantages remain until 
today. It took until the 70’s and 80’s of the last century before the idea of biofuels was 
revisited. Among others, an important milestone here was the ‘Clean Air Act’ by the 
American Environmental Protection Agency (EPA) in 1970 which set the standard for 
emissions and fossil fuel additives. Also the 1973-1974 Arab oil embargo and the Iranian 
revolution (1978-1979) and the resulting oil-scarceness gave the renewed development of 
biofuels an impulse. The American endeavor for independence of foreign oils pushed the 
development of biofuels further with the Energy Policy Act (EPACT; 1992). Even today, the 
biofuel market is influenced by the political climate and the crude oil price.  
However, optimizations of the diesel engine towards fossil fuels made vegetable oils 
inapplicable as an energy source due to their high viscosity. Already in 1937 the Belgium 
inventor G. Chavanne patented the idea of a transesterification method, in which vegetable 
oils and short alcohols were converted into fatty acid alkyl esters with glycerol as a byproduct 
(Figure 1.2). Fatty acid alkyl esters are a very attractive diesel fuel replacement. This 
transesterification reaction is at the base of the current generation of biodiesel, which is the 
trade name for fatty acid methyl esters (FAMEs). Currently the two major biofuels available 
on large scale are ethanol with   ̴130 billion liter a year in 2014, as a gasoline substitute, which 
is a natural product of yeast fermentation and FAMEs, with a market size of more than ~30 
billion liter a year (in 2014) as a crude oil diesel replacer.  
Besides governmentally organized projects and initiatives (like for example ‘The Billion Tons 
Study’; US) for future exploration of the biofuel scope, several industrial initiatives, mostly 
originating from chemical and/or oil companies, have taken shape and are steadily investing 
into the development of other biofuels. These cooperations show the commercial interest in 
sustainable cell factories for fuel production and are an indication for the strong commercial 
trust in successful and fast advanced biofuel implementation in a short future. The political 
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support to use current biofuels and to develop the next generation sustainable biofuels by 
academic and industrial researchers might be another motivation to position this generation 
biofuels on the market and to push forward to the next sustainable but also commercially 
attractive generation of biofuels. The development and production of isobutanol, an ethanol 
replacer with a higher energy density, is for example tackled by ButamaxTM 
(www.butamax.com; joint venture of BP and DuPont) and Gevo (www.gevo.com). Dupont is 
also developing the production of 1,3-propanediol. BP and Verenium Corporation 
(www.verenium.com) cooperate on second generation bioethanol and ExxonMobil entered a 
joint venture with Synthetic Genomics on the production of microalgae based biodiesel. 
Amyris Inc (www.amyris.com; large shareholder: Total) is paving the road for the application 
of isoprenoid derived products, i.e. farnesene (biodiesel), whereas LS9 is producing fatty acid 
derived products in E. coli but was recently acquired by Renewable Energy Group (REG; 
www.regi.com). Other initiatives, like Joules Unlimited (www.jouleunlimited.com) are using 
phototrophic microbes for energy conversion. There are many other companies like Codexis 
(www.codexis.com), Raizen (www.raizen.com), Solazyme (www.solazyme.com), Mascoma 
Corporation (www.mascoma.com), Synthetic Genomics (www.syntheticgenomics.som), 
Novozymes (www.novozymes.com), and Genencor (www.biosciences.dupont.com) that are 
exploring the biofuel market.  
 
Figure 1.2: Chemical reaction of FAMEs from oils and lipids and biochemical conversion of FAEEs from free 
fatty acids. 
1.3. Advantage of FAEEs  
Novel fuel molecules (advanced biofuels) should possess superior fuel and operational 
properties to compete with the current fossil fuel market. Both major currently available 
biofuels, ethanol and biodiesel, however, suffer from major drawbacks. The short chained 
ethanol for example has lower molecular properties for combustion purposes than crude oil 
gasoline and can therefore only be blended into this fuel. Therefore it is, among others, 
important to design new sustainable fuels and extend the variety of fuels with fuel molecules 
with improved physical properties to achieve a high energy density, a low octane number and 
a suitable viscosity. Candidates for advanced biofuels are beyond others longer chain alcohols 
(1-propanol, 1-butanol, isobutanol, 2-methyl-1-butanol, isopropanol etc.), biodiesels (fatty 
acid ethyl esters (FAEEs) or (isoprenoic-) farnesane) and alkanes or alkenes. Furthermore it is 
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important to have a reliable, storable, flexible, safe and clean fuel that can compete 
economically with fossil fuels. It is important to note that each transportation node requires a 
fuel with specific properties. Additionally, there are fine-tuned differences required within 
one transportation node due to, for example geographical location. A general rule of thumb is 
that the faster the transportation the higher the quality of the fuel should be. 
Next to the chemical and physical properties of the fuel molecule, the reliability of the 
substrate source is also important. The current process of FAME production requires a large 
supply of lipids. These lipids are mainly harvested from rapeseed and soybean plants but the 
vegetable oils can also be obtained among others from palm, coconut, peanut and sunflower. 
However, the above mentioned substrate sources do not yield sufficient amounts of vegetable 
oil per (agricultural) area and are therefore not able to supply the large amount of lipids 
necessary for bulk FAME production. The second metabolite, methanol, is currently obtained 
from fossil oil resources and is as such a less sustainable substrate. Another disadvantage is 
the large amount of glycerol being produced during the formation of FAMEs.  An attractive 
alternative is the production of fatty acid ethyl esters (FAEEs), an equally well suitable 
biodiesel. FAEEs can be produced by microbial cell factories, which use sugar as a source of 
energy. Sugars can be grown and harvested more efficiently than lipids and are currently also 
used for several other products using cell factories as a production platform. As a substrate 
source, sugars are therefore more flexible, storable and reliable than lipids. During microbial 
production, the precursors, acyl-CoA (activated form of free fatty acids (FFA)) and ethanol 
are converted by a transesterification reaction, catalyzed by a wax ester synthase into FAEE 
and water [7]. No byproduct is formed and therefore the theoretical carbon yield of the 
transesterification reaction is 100% (Figure 1.2), which is around 5% higher than the yield 
from the classical transesterification reaction converting vegetable oils and methanol into 
FAME and glycerol. The byproduct, glycerol, is responsible for the lower yield during the 
classical chemical reaction.  
1.4. The microbe – choosing between fat, smart and robust 
Already for centuries, humans have been selecting microbes with a desired phenotypical traits 
and used them for different, industrial, processes. One of the first examples of the cell factory 
concept was the production of penicillin by Penicillium chrysogenum. During the Second 
World War there was a high demand for antibiotics for wounded soldiers. The P. 
chrysogenum cell factory was suitable of producing penicillin and could therefore ‘save many 
lives’. This would not have been possible by chemical synthesis of the antibiotic, which was 
only established in 1957. Another important milestone was the production of the first 
‘heterologous’ protein, human insulin for diabetic patients, produced in a recombinant E. coli 
cell factory in the early eighties [8]. Before, animal insulin was extracted from mostly pig 
pancreas, which was difficult to supply and had different activity due to the fact that it was 
animal insulin. A third microbe with large industrial impact is the yeast Saccharomyces 
cerevisiae, which has been optimized for the production of ethanol, resulting in yields close to 
the theoretical yield. S. cerevisiae is furthermore very robust against several industrial stresses 
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and has been (genetically) engineered for many other production advantages. Nowadays, 
some of the most widely used, heterologous cell factories include E. coli, S. 
cerevisiae, Bacillus subtilis, and Streptomyces coelicolor, but many other hosts exist for 
different purposes. Overall, a broad range of (microbial, mammalian and insect) cell factories 
have specific physiological traits and have therefore been incorporated to the cell factory 
family [9, 10]. From a general industrial point of view, algae, fungi, psychrophilic bacteria, 
mosses and others are gaining in interest [11-14].  
For microbial production of FAEEs, the question what microbial host to use is a relevant one. 
In general, the product, the metabolic conversion and the substrates affect the choice for a 
host. For the direct, cellular conversion of sugar into FAEEs several factors are important. 
First of all, FAEEs are supposed to become a bulk product. Therefore the organism of choice 
should be able to handle large scale and long term cultivation conditions in low-cost media. 
Therefore the host has to be genetically stable while expressing heterologous pathways. 
Additionally, the conversion of glucose into FAEEs requires that most of the consumed 
carbon is used for the production of the long fatty acid chain and the minor part being 
converted into ethanol. An organism with the desired metabolic pathway or that allows 
introduction of the pathway is required. One possibility is an oleaginous organism, which 
produces large amounts of lipids. Examples of oleaginous organisms which were reported to 
accumulate lipids up to 65–75% of their cell dry weight (CDW) are Botryococcus braunii, 
Gordonia sp., Humicola lanuginose or Lipomyces starkeyi [15-19]. Microbial hosts, for 
industrial purposes, should in general be genetically manipulated to improve product yield, 
titer and productivity, and additionally have to introduce the FAEE pathway. It is therefore 
inevitable to have (good) genetic tools available to manipulate the host. Unfortunately, above 
listed organism do not fulfill these requirements. 
The oleaginous yeast Yarrowia lipolytica stores lipids up to 36% of CDW and is used as 
industrial workhorse and could therefore be an attractive host for microbial FAEEs production 
[20-22]. Additionally, its genome has been sequenced [23] because of increased industrial 
interest for e.g. citric acid production, protein production, intracellular lipids and 
bioremediation [24, 25]. However, there is a necessity to metabolically engineer Y. lipolytica 
for the production of FAEEs because it naturally contains no wax ester synthase and is not 
able to produce ethanol, one of the FAEE precursors during direct in vivo conversion from 
sugars. Genetic modifications, however, are not straight forward in Y. lipolytica [26, 27]. 
Because of this lack of a decent genetic tool-box no direct conversion from sugars into 
FAEEs has been reported in Y. lipolytica so far. The realization of oleaginous hosts for the 
production of FAEEs is unsuitable within a close future because of the missing valuable 
engineering knowledge of these organisms. 
In contrast, S. cerevisiae and E. coli were not only used as microbial platforms for cell 
factories for many years but also as model organisms for fundamental research. For both 
organisms, the availability of an established genetic toolbox, large physiological experience, 
accessibility to metabolic engineering and growth on simple inexpensive medium with 
minimal additions increased their applicability as industrial host [7, 28-31]. Due to the fact 
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that E. coli is a small and therefore fast growing organism, due to its lack of 
compartmentalization and due to its easily accessible DNA, it would be very suitable for 
engineering the FAEEs pathways in this microbial host. The first examples of FAEEs 
production in a heterologous organism were therefore also from E. coli research [32-34]. 
However, E. coli has the disadvantage of being susceptible to attack by bacteriophages and 
therefore its performance in large scale and long term cultivations in low-cost media is 
suboptimal.  
The yeast S. cerevisiae is not only widely accessible for metabolic engineering purposes, but 
also has a long history of being used in industrial large scale fermentations and therefore 
represents an ideal candidate as a FAEEs producing platform. S. cerevisiae is a natural 
ethanol producing microbe, however, only 10% of its CDW consists of lipids [35]. Therefore, 
improving the availability of acyl-CoA for the formation of FAEEs is considered to be the 
main engineering challenge in S. cerevisiae. The combined knowledge of bioprocess 
engineering and metabolic engineering together with the availability of a large toolbox 
provides an excellent starting position for the creation of an economically competitive 
production platform for the biodiesel FAEE.  
1.5. The microbial cell factory process 
The successful implementation of any microbe in an industrial setting should address three 
major points: the feedstock, the bioconversion process and the product purification. Only 
optimization of all three fields will result in a successful, economically feasible and 
competitive process. A centralized position in the interplay is reserved to the microbe, which 
has to interact with its substrate and convert it into the product, and which dictates the 
downstream processing, and is therefore attracting most engineering attention (Figure 1.3).  
1.5.1. Feedstock  
In general, the most costly part of the cell factory process is the substrate provided to the 
microbes. Therefore, the economical success of microbial cell factories for bulk products is 
dependent on the ability to consume cheap substrates from cellulosic biomass. While 
microbes can consume most exotic substrates, S. cerevisiae prefers to consume energy rich 
glucose. Additionally most microbes cannot or have difficulties consuming sugar mixtures 
(C5 and C6) but recent engineering of yeast S. cerevisiae did not only enable successive 
consumption of both sugars, but also enabled the co-catabolism of these sugars [36, 37]. 
However, for bulk products like FAEEs, pure glucose is too expensive and consequently 
cheaper feedstocks such as sugarcane (Brazil), corn (Northern America) or sugar beets 
(Europe) are used. As S. cerevisiae cannot consume large polysaccharides, these need to be 
depolymerized mostly by cellulases and hemicellulases into monosaccharides before cellular 
uptake and conversion [38, 39]. On a longer term, microbial cell factories are meant to 
consume substrates (from specially designed crops) that are non/less-competitive with food 
consumption and in a long future photoautotrophic mechanism might be preferred [40]. There 
are large engineering efforts to create a better interaction between the release of sugar 
mixtures from plant materials and the microbes consuming them. Main efforts focus on fast 
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and efficient consumption of multiple sugars by microbes, enzyme technology for 
lignocellulosic degradation, design of increased cellular robustness to stand the high 
impurities in the lignocellulosic feedstocks and design for fast growing, non food-
competitive, high sugar containing plants [41, 42].  
 
 
Figure 1.3: The connection between the different fields of expertise that come together for the construction of 
cell factories. 
1.5.2. Downstream processing 
The fermentation broth is a mixture of water, yeast, salts, the product and other metabolites 
from which the target molecules have to be separated and purified. Dependent on the 
chemical properties of the compounds of interest and the composition of the fermentation 
broth the separation can be challenging and costly. Especially energy consumption can add up 
to the total costs [43]. Therefore it is essential to design a downstream process with minimal 
product loss that results in the desired purity of the product, at lowest cost possible. FAEE 
molecules are hydrophobic therefore create separate layer when secreted by the cell and can 
therefore be separated and purified relatively easily [40]. More information on the economics 
of down-stream processing can be found in [43]. 
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1.5.3. Bioconversion process 
The microbial conversion of substrate to product is the core of the cell factory process and 
due to its high impact, large engineering efforts are performed in this area. The harvest of a 
product yield as close to the theoretical yield as possible is important for economical 
feasibility and additionally, ‘time is money’ and therefore the product should be converted in 
a minimum amount of time. Essential parameters for an economically feasible process are the 
product yield, the titer and the production rate [44].  
1.6. Microbial design 
1.6.1. Engineering the metabolism 
Traditionally, microbial cell factories were improved by mutagenesis and screening for 
specific properties of microbes, like high production rates, yields and titers. From the 1980s 
onwards the development of cell factories brought its first engineering successes by targeted 
and rational strain design. Nascent recombinant DNA technologies supported the first cell 
factory successes, as an example the production of the earlier mentioned recombinant insulin. 
However, strain engineering for biotechnological purposes has a fundamental different 
objective than the objective of the cell. Often the engineering purpose acts against the cells 
nature, for example in the case of shifting the metabolism entirely towards the product and 
minimizing byproduct formation. Knowledge of targeted genetic modifications, 
computational modulations, and cell physiology is a powerful combination, which led to the 
development of the field of metabolic engineering, originally coined by Bailey and 
Stephanopoulos [45-48]. The field of metabolic engineering, which deeply penetrated the area 
of microbial cell factories and became a widespread platform for the production of molecules, 
has been discussed and reviewed extensively and has also been defined differently [49]. Here 
the definition given in the metabolic engineering textbook by Stephanopoulos, Aristidou and 
Nielsen was followed. 
 
Metabolic engineering 
‘The directed improvement of product formation or cellular properties through the 
modification of specific biochemical reaction(s) or the introduction of new one(s) with the use 
of recombinant DNA technology.’[35] 
 
The performance of many different cell factories, including the FAEEs production in S. 
cerevisiae, was improved by regulation of the expression of endogenous and heterologous 
genes and specific gene knockouts. However, without considering the whole cellular system 
the microbial cell factory is prone to suboptimal performance and therefore it became clear 
that system wide behavior of the cell is an important factor for the consideration of metabolic 
engineering targets. 
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1.6.2. System wide perspectives 
The field of metabolic engineering, and therefore the creation of new phenotypes, is driven 
forward by understanding complex cellular systems. The system wide perspective provided 
by systems biology, which shed light into hidden cellular properties, has several advantages 
compared to traditional molecular biology tools in which only few metabolic engineering 
features could be evaluated at the same time. Systems biology has therefore changed and 
advanced the analysis of cellular phenotypes for industrial biotechnology and metabolic 
engineering. 
Omic technologies are the driving power for analyzing large numbers of cellular components 
for industrial cell factories. Transcription analysis is the most commonly used technique in 
metabolic engineering and demonstrated its value as it screens genome wide messenger RNA 
levels which allows integration with genome wide metabolic models [50-55]. The first system 
wide analysis at the transcriptome level of a FAEE cell factory was performed during this 
work. However, messenger RNA levels and protein levels do not necessary show a direct 
correlation [56] and therefore the mass spectrometry based proteomics enables the monitoring 
of large parts of the cellular proteome [57, 58]. The use of mass spectrometry also enables a 
relative high-throughput measure of metabolic pathway intermediates, which is referred to as 
metabolomics. However, challenges related to sampling and extraction [59] as well as to 
obtaining quantitative information about the metabolite levels remain [60]. The different omic 
techniques can reveal essential parts within a specific cellular layer and especially metabolic 
fluxes represent the cellular phenotype as integrated output of all cellular components, such as 
genes, transcripts, proteins and metabolites [61-63]. 
An import milestone for recombinant DNA techniques was complete genome sequencing of 
organisms. Genome sequencing enables the possibility of reversed engineering which in turn 
facilitated the identification of driving mutations behind adaptively evolved strains [64, 65]. 
The more recent genome wide RNA sequencing improved expressing profiling of organisms 
and might provide more information for the integration of metabolic networks with regulatory 
networks or cellular stress and will further optimize the understanding of cell factory 
engineering [66]. The use of additional omics technologies for detailed phenotypic analysis is 
still important in order to identify driving mutations, despite the existing possibility to identify 
genomic mutations [65], in particular because adaptive evolution often results in appearance 
of many silent mutations that can be difficult to filter out. The combination of different omics 
technologies has been found to be very worthwhile to understand how gene deletions or gene 
overexpressions lead to a certain phenotype. This has been demonstrated to be valuable for 
gaining insight into complex regulatory pathways involved in controlling metabolism. 
Investigation of the yeast protein kinase Snf1 [67], the identification of transcription factors 
determining metabolic fluxes in yeast and E. coli [68, 69] and the interaction between Snf1 
and protein kinase Tor1 in yeast [70] have been good examples for this. As it will be 
discussed later on, for example Snf1-dependent phosphorylation attenuates the activity of 
acetyl-CoA carboxylase and therefore plays an important role for the production of FAEEs in 
S. cerevisiae. 
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Since the foundation of the field of metabolic engineering, mathematical modeling has been 
an integral part of it, but especially with the advancement of genome scale metabolic models 
the models have been directly coupled with identification of metabolic engineering targets 
and also allow the evaluation of the global physiology of a cell. The mathematical modeling 
of metabolic networks [55, 71-74] and the development of online tools [62, 63] has been 
reviewed extensively. 
 
The rather new field of synthetic biology might enable the creation of novel regulatory 
mechanism for metabolic pathways and therewith maximizing the metabolic flux and the 
strain development [75]. The ability to turn on and off cellular metabolism, adjusting it to its 
environment and dynamically control its (heterologous) pathways will push the creation of 
flexible cell factories forward [76, 77]. Rapid development of a technological platform for 
microbial design for cell factories will enhance by integration of the field of metabolic 
engineering, systems biology screening and synthetic biology tools, also described as systems 
metabolic engineering [31].  
1.7. FAEE producing cell factories 
The early production of FAEEs in microbial hosts was established due to the appliance of 
above briefly described metabolic engineering strategies. These first metabolic engineering 
projects were performed in Escherichia coli [32-34] and efforts on combining strategies 
resulted in a highly engineered E. coli strain with cytosolic expression of thioesterase ’TesA, 
overexpression of acyl-CoA ligase, inhibition of β-oxidation, introduction of the alcohol 
synthesis pathway from Zymomonas mobilis, and high expression of a heterologous wax ester 
synthase (atfA), which led to production of 674 mg FAEEs/l during cultivation on glucose 
[78]. 
For several reasons, which were discussed earlier, researchers switched to the production of 
FAEEs in the yeast S. cerevisiae and therefore some of the engineering history is briefly 
described here. The disruption of acyl-CoA competing pathways (see chapter 3 for details), in 
combination with the over expression of the heterologous ws2 from Marinobacter 
hydrocarbonoclasticus resulted in a yeast strain with the inability to synthesize storage lipids 
and an FAEE production of 17.2 mg/l [32, 79, 80]. Another research combined expression of 
Acc1S1157A,S659A, an acetyl-CoA carboxylase variant with partly abolished posttranslational 
regulation, and ws2 resulted in an FAEE production of 15.8 mg/l [81]. Furthermore, 
overexpression of native ACC1, FAS1 and FAS2 and the deletion of the β-oxidation pathway 
in combination with expression of a wax ester synthase from Acinetobacter baylyi (AtfA) 
resulted in an FAEE production of 5.44 mg/l [82]. Following up on the previous work, an 
abolished β-oxidation pathway, disruption of acyl-CoA synthetase gene FAA2 and acyl-CoA 
transporter gene PXA2 as well as elimination of acyl-CoA binding protein Acb1 in 
combination with expression of codon optimized atfA under nitrogen limitation cultivation 
conditions resulted in a FAEE titer of 13.9 mg/l [83]. One study focused on increased 
integrated copy numbers of the wax ester synthase, which were randomly integrated into the 
genome, and resulted in a total of six copies of ws2 and a FAEE titer of 34 mg l-1 [84]. The 
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brief description of metabolic engineering strategies on the previous performed work 
indicates the interest to establish a FAEEs producing platform in S. cerevisiae.  
1.8. Outline of thesis 
This work shows the essence of microbial cell factory design with a focus on the central part 
of engineering the microbe, S. cerevisiae, for the establishment of fatty acid ethyl ester 
production. During the introduction (Chapter 1) argumentation and reasoning for the concept 
of the microbial cell factory in a S. cerevisiae host for the production of fatty acid ethyl esters 
was given. The following chapters describe the research performed during this study. The 
different chapters are organized into different categories that play an important role for the 
development of a FAEE cell factory. 
Chapter 2 ‘metabolic pathway engineering’ describes the necessity of several techniques 
which are required for the construction of long and complicated pathways. The development 
of the molecular biology techniques is necessary to reduce the time and therewith the 
investment involved for constructing new cell factories. During the time of this study several 
different techniques were used for the construction of the strains described in chapter 2. 
However, not all microbial techniques were included in the publications (paper II and paper 
III) and therefore metabolic pathway engineering is reviewed in a broader perspective, here. 
Chapter 3, ‘yeast metabolism and fatty acid ethyl esters’ describes the core of S. 
cerevisiae’s metabolism and the pathway engineering strategies for the development of an 
industrial microbial system which is able to produce the heterologous product, FAEEs. First 
of all, wax ester synthase is described as the key-enzyme for the conversion of fatty acyl-CoA 
and ethanol into FAEEs. Several endogenous as well as heterologous genes were up-regulated 
to improve the supply of metabolite intermediates ethanol and acyl-CoA. Additional, a 
heterologous pentose phosphate pathway was introduced into the host cell which rechanneled 
the carbon flow through the pentose phosphate pathway, producing NADPH as a byproduct. 
Finally, different metabolic engineering strategies were combined and stably integrated into 
the yeast chromosome. The results presented in this chapter find their origin mostly in paper 
II and paper III. 
Chapter 4, ‘phenotypic characterization’ describes the techniques involved to understand 
the metabolic changes in a constructed cell factory. First of all, phenotypes, physiological 
behavior, and the important role of systems wide ‘omic’ analyzing methods were elucidated. 
The results presented here demonstrate the importance of systems wide transcriptional 
regulation for the production of FAEEs in S. cerevisiae. The correct interpretation of the 
combination of the analytical results leads to new rounds of strain engineering and strain 
improvement. The results presented here find their origin mostly in paper IV. 
The last chapter, ‘conclusion and future perspective’ explains the lessons learned during the 
performed studies and looks towards the scientific challenges that lie ahead for paving the 
ideal road for the implementation of the FAEE cell factory.  
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2. Metabolic Pathway Engineering 
2.1. Background 
To construct microbial cell factories one of the most important elements is the engineering of 
the metabolic pathways. Well engineered cell factories have significant advantages in 
physiological characteristics and therefore reach for example better yields, titers or 
robustness. The ease to apply genetic modifications in S. cerevisiae is essential for industrial 
competitiveness of these yeast cell factories. Heterologous genes can be inserted, endogenous 
genes or promoters can be deleted/replaced, the compartmentalization of the encoded proteins 
can be changed and enzymes can be switched on or off for regulation purposes. Typically, a 
combination of several of these strategies forms the core of de novo pathway engineering 
[85]. Where traditionally the modification of one gene was targeted within the field of genetic 
engineering, the field of metabolic engineering approaches the overall efficiency of the 
metabolic pathway in connection to the fitness of the microbial cell factory. Recent 
developments in the field tilt towards an engineering approach with several parallel 
modifications of an increased amount of sensitively regulated genes, which could be adapted 
fast towards new understanding of the microbial metabolism [77, 86]. Therefore and due to 
the fact that pathway engineering is a highly costly and time consuming workmanship, there 
is a parallel demand for the development of fast, cheap, reliable, robust and high-throughput 
metabolic pathway engineering techniques. In this chapter, the development of pathway 
construction is discussed to give a view on the challenges, drawbacks and hurdles to be dealt 
with.   
2.2. Pathway engineering’s core architecture 
The fundament of gene expression needs to be well understood in a detailed way before more 
complex multi-gene modifications can be performed. In S. cerevisiae it is possible to express 
genes (or open reading frames (ORFs)) from plasmids as well as from genomic DNA. In both 
cases, when expressed, it is recommended that the functional gene sequence is preceded by a 
promoter and an optional Kozak sequence [87] to increase transcription and followed by a 
terminator. The DNA sequence starts with the ATG start codon whereas it ends with a 
terminating stop codon (TAA, TAG or TGA). The gene of interest (GOI) forms the core of 
the construct but can be accompanied by different, exchangeable promoters and terminators. 
Especially the promoter site is important for the regulation of the gene expression and 
therefore of special interest in metabolic engineering. 
In general, for S. cerevisiae, two different types of promoters can be distinguished; 
constitutive and regulatory promoters. The choice of the promoter is essential for achieving a 
desired expression level of the gene, which can differ by four orders of magnitude [85]. The 
strongest and therefore most commonly used constitutive promoters are among others 
pPGK1, pADH1 and pTEF1, which have been used during this work (paper II, III and IV) 
for the overexpression of the genes ws2, acsSEL641P, ACB1 (all preceded by pTEF) and ALD6, 
ACC1ser1157ala,ser659ala (both preceded by pPGK1). These strong promoters were used to 
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demonstrate an increased yield of FAEEs and product intermediates and were therefore 
important. However, in the future it will be necessary to fine-tune the individual gene 
expressions of the overall pathway, in which weaker constitutive promoters and regulatory 
promoters will become more meaningful. Regulatory promoters are commonly induced by 
specific signals, but as well by environmental changes. For example pHXT7 (paper II) or 
pADH2 [88] are glucose repressed and will be useful in industrial fermentative applications to 
induce genes in pathways needed once glucose is depleted. A truncated version of the 
promoter HXT7, however prevents glucose repression and is therefore active during glucose 
consumption [89]. To improve the production of FAEEs this truncated version of HXT7 was 
used for the expression of gene ADH2 in paper III and paper IV. During industrial 
processes the costs of induction of such promoters might be a limiting factor and therefore it 
is important to search for promoters which are regulated by cheap inducers [77]. In general it 
should be considered that the application of strong promoters might lead to high yields and 
titers, but that after evaluation and fine-tuning of the metabolic pathway the adaption towards 
regulatory or weaker promoters for individual genes, part of the overall pathway, might lead 
to an increased productivity. In addition, it should be kept in mind that unnecessary 
overexpression of genes and plasmids might also cause stress, by drain of co-factors or other 
metabolites, by accumulation of (toxic) intermediates, by negative feedback loops or by the 
development of instability for the cell. However, it seems unlikely that FAEEs are toxic to S. 
cerevisiae at the concentrations produced here (see next chapter). There was no negative 
effect on cell growth when 1 g/l of myristic acid ethyl esters were added to the medium (data 
not shown). In paper II, two assembled pathways (resulting in plasmids larger than 15 kb) 
were expressed on 2-micron plasmids resulting in a high copy numbers and therefore high 
expression. Although it is well known that expression of pathway enzymes from self-
replicating plasmids might cause a metabolic burden on the host cell and that both plasmid 
size and promoter strengths influence the stability of the plasmid and therefore the gene 
expression when propagated in S. cerevisiae [39-41] most previous work on modifications for 
FAEE production in yeast were based on plasmids. The successive segregational and 
structural instability makes these strains non-suitable for industrial fermentations [90-92]. 
Strains that were constructed based on plasmids (in paper II) indeed showed a high clonal 
variation (see chapter 3). 
Fine-tuning and balancing of the expression levels of individual genes within a larger 
metabolic pathway is essential to reach optimal functionality of metabolic pathways, and 
therefore there is extensive research to create an enlarged promoter library for different 
inducible promoters as well as for stronger and weaker constitutive promoters. New promoter 
properties can for example be achieved by combining regulatory elements derived from 
different promoters and new promoter-libraries are created by error-prone PCR from existing 
yeast promoters [85, 93, 94]. 
Another difficulty is the fact that DNA sequences coding for functional proteins in an original 
organism might not lead to functional expressions in the S. cerevisiae host. Therefore, codon 
optimization is essential for the functionality of heterologous genes in S. cerevisiae. 
Understanding codon-optimization will dramatically improve predictability of expression of 
15 
 
ORFs but it should be kept in mind that other parameters, like the choice of promoter region 
also controls gene regulation [95-100]. All in all, understanding what influences the 
expression levels of (heterologous) genes, will improve the final outcome of metabolic 
engineered pathways including multiple modifications. 
 
The proper termination of transcription is required for the stability of mRNA and is therefore 
also important for the expression level. However, the choice of a terminator is less sensitive 
towards the final expression level of a gene compared to the choice of promoter. The 
terminators applied in paper II, III and IV, tADH1, tCYC1 and tTEF1, belong to the most 
commonly used terminators in S. cerevisiae [85]. 
In general there are two major expression platforms for expressing genes and pathways in 
yeast. A very common way is plasmid based expression. Overexpression of genes typically 
relies on high-copy yeast episomal plasmids (YEps) which come with the risk of an energy 
burden by transcription and translation costs and a metabolic burden due to drain of 
nucleotides and amino acids. Secondly, expression of genes after integration into the host 
genome constitutes a more stable option for a cell factory with consequently several 
advantages on plasmid based expression of genes [90, 101, 102]. Plasmids, however, play an 
important role for the assembly of metabolic pathways, which involve one or more promoter-
gene terminator bricks.  
Results in paper III demonstrated that chromosomal integration of the metabolic engineering 
strategy into the chromosomes of S. cerevisiae resulted in stable expression and it was 
therefore possible to quantitatively evaluate complex engineering strategies involving several 
different genetic modifications. This combined overexpression of the six genes on two 2μ 
plasmids with a total size of 15 kb and 18 kb however, decreased the yield of FAEE in S. 
cerevisiae (unpublished results) and was therefore due the instability of plasmid expression 
not possible. The study also demonstrated much reduced clonal variation of the integrated 
strains in comparison to the plasmid-based strains used in previous studies. A very good 
starting point for further engineering was established due to the success of chromosomal 
integration e.g. evaluation of the effect of increased expression of the wax ester synthase, 
which is likely to be limiting production the engineered strains.  
2.2.1. Selection markers 
While introducing genetic traits into host cells, there is an interest to select on the cells 
expressing correct insertions, which is performed by the use of marker genes. Different 
selection markers have been developed for this reason, which includes prototrophic markers 
(require the availability of an auxotrophic host strain carrying a nonfunctional version of the 
respective gene; ex.: URA3, HIS3 or LEU2), markers conferring drug resistance, autoselection 
markers (marker gene is essential for cell viability) and counter selectable markers (selecting 
for absence of marker gene). An extensive review on selection markers was reviewed by 
Siewers [103]. Despite the variety of selection markers available in S. cerevisiae, mostly only 
few selection markers are used [103]. During this work, marker genes URA3 and HIS3 were 
used (paper II and III). A reason for the limited use of the full variety of selection markers is 
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the availability of background strains that allow the use of different auxotrophic markers. To 
perform a second round of metabolic modifications (with the same selection marker) on the 
host cell, the selection marker needs to be recycled. The marker recycling is mainly done in 
three different ways: direct repeats [104-106] which are looped out by homologous 
recombination, site specific recombinases in which the Cre/loxP system from bacteriophage 
P1 is most commonly used [107, 108] or bridging oligonucleotides, which is a scar-free 
approach working with overlapping oligonucleotides, carrying up- and downstream sequences 
of the marker cassette and homologous recombination [109]. As an example: marker gene 
URA3 is able to convert 5-fluoroorotic acid (5FOA) into a toxic compound (5-fluorouracil) 
and therefore selects on cells without gene URA3 [110]. The recent development for easier 
recyclable selection markers in S. cerevisiae, performed by Jensen et al. (2013) [90] and 
Kuijpers et al. (2014) [111] indicates the industrial demand for good selection pressure.  
2.2.2. Limitation of large pathway assembly 
The necessity for each gene in a sequential pathway to individually be regulated by a unique 
promoter and a terminator creates a major drawback for the integration of large multigene 
pathways and increases the risk of recombinations between the constructs. A solution to this 
problem was i.a. given by the development of scattered integration sites along the 
chromosomes [112], and in addition to this, the development of polycistronic (several genes 
under the control of one promoter) expression of genes is most interesting (reviewed by David 
et al., 2014 [113]). However, disadvantages might be, respectively, the limitation of the 
amount of promoters and terminators for each integration site and the lack of fine-tuning for 
individual gene expression in the latter case. 
2.3. From gene to pathway 
Increased availability of genome sequence data and improved metabolic models, which lead 
to identification of multiple metabolic engineering targets, shifted the limitation of cell 
factory design towards strain construction [114-116]. Consequently, efforts to improve 
pathway engineering have been on the rise. Pathway expression, as described earlier, is done 
on two different platforms, plasmids or chromosomes, where the latter is the preferred method 
of pathway expression due to above mentioned limitation of plasmid based gene expression. 
Integration of metabolic pathways into the yeast chromosome has traditionally been 
performed via cloning into integrative plasmids, which are subsequent linearized before 
transformed into the yeast, followed by the insertion into the chromosome. Therefore, 
plasmids take an essential function for pathway assembly. Traditionally, cloning was 
dependent on restriction-ligation methods; however, the demand for high-throughput pathway 
assembly methods led to the development of new pathway construction methods. Several 
methods for pathway assembly are widely used (Gibson cloning [117], SLIC [118] or 
InFusion [119]), however, here only a couple of recent examples of pathway assembly 
methods are described. 
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2.3.1. Uracil-Specific Excision Reagent cloning 
Uracil-Specific Excision Reagent (USER) cloning was developed for fast, high-throughput 
and stable cloning. The development of the method started in the early 1990s with the uracil 
excision based cloning (ligase free Uracil DNA Glycosylase (UDG) cloning) which 
represented an alternative to the disadvantages of restriction-ligation cloning [120-123]. The 
principle of the method was based on PCR amplification of inserts and vector that were 
constructed with overlapping primers. The primers contained at least four deoxyuridines (dU) 
which, after treatment with UDG, resulted in 3’ single stranded overhangs of the insert, 
complementary to the single stranded overhangs of the vector. Cross-annealing of vector and 
insert resulted in successful scar-less cloning [122, 123] but had several limitations preventing 
it for wide usage [122-124]. Therefore, improvements resulted in a vector and insert with 
single stranded overhangs with specifically designed nucleotide composition preventing (self-
) complementation and resulting in flexible lengths of the overhang permitting the assembly 
of multiple inserts into the vector. An important milestone for the development of the method 
was the insertion of a small restriction cassette which enabled, first linearization of the vector 
using AsiSI restriction enzyme and secondly the creation of specific overhangs by nicking the 
sequence with Nb.BsmI. An advantage of the use of these two restriction endonucleases 
prevents the plasmid for proof-reading mistakes that might occur during PCR amplification. 
The PCR fragments are amplified with Taq DNA polymerase or Pfu DNA polymerase, which 
are both able to amplify the dU residue. Recently a (point-) mutated version of PfuTurbo Cx 
hotstart was created with even slightly better performance (Pfu X7 DNA polymerase). The 3’ 
end single stranded extensions of the PCR products are generated by removing the dU residue 
by the USER TM enzyme. The deoxyuridine-excision reagent (USER TM enzyme) is a mix 
of UDG and DNA glycosylase-lyase endonuclease VIII which is able to break the 
phosphodiester backbone at the 3’ and 5’ site of the dU [121, 124, 125].  
2.3.2. Circular Polymerase Extension Cloning 
Circular Polymerase Extension Cloning (CPEC): Restriction digestion, ligation or single 
stranded overhangs are necessary in several different cloning techniques but also cause 
difficulties while performing the cloning. To circumvent these techniques, CPEC was 
developed, which only requires the use of a high fidelity DNA polymerase during the one step 
simultaneous in vitro assembling of multiple inserts into any vector [95, 126]. CPEC solely 
relies on the mechanism of homologous overlapping sequences (20-25 bp) at the end of the 
linearized inserts and the linearized vector which form a circular insert(s)-vector product. A 
limitation of CPEC is the compulsory use of high fidelity proofreading DNA polymerases, 
which could be problematic, especially with sequences with repeats or GC-rich parts. 
 
Independent of which cloning technique is used, it is important to gain a high efficiency in 
cloning and therefore reduce false positives. One of the possible reasons to lose efficiency is 
the reannealing  and consequently recirculization of the vectors. While using CPEC, it has 
been demonstrated that treatment with methylation sensitive DpnI restriction enzyme resulted 
in more efficient cloning [95, 127]. This enzyme digests all methylated plasmids produced by 
a bacterial host and therefore automatically selects for linearized products. This technique can 
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generally be applied for similar cloning techniques and has already shown its usefulness for 
USER-cloning in the Nielsen lab. 
2.3.3. Ligase Cycling Reaction 
Ligase cycling reaction: The development of the ligase cycling reaction (LCR) method for 
plasmid construction pioneered with the detection of single-nucleotide polymorphisms in 
genomic template DNA with a high specificity [128-130]. Single stranded oligonucleotides 
are designed, complementary to the ends of two DNA parts to assemble these DNA 
sequences. The LCR-process is initiated when the bridging oligonucleotides anneal to the two 
complementary DNA parts after a denaturation step at high temperature. A thermostable 
ligase then joins the DNA backbones via a phosphodiester bond in a scar-less manner. This 
denaturation-annealing-ligating reaction of a single strand DNA serves as a template for the 
double stranded DNA string and by applying different temperature cycles, many DNA parts 
can be assembled into complex DNA constructs. Initially only a 40% success rate was 
achieved with this method [128] whereas later improvement of ligase, PCR and primer 
conditions resulted in a success rate of 60-100% [86]. This is comparable to the process of 
homologous recombination in yeast (see section below), however constituting a faster option 
[86]. 
2.3.4. Homologous Recombination 
Homologous recombination is a process functional in S. cerevisiae to secure the repair of a 
DNA sequence after double strand breakage. Due to the efficiency and simple working 
procedure the use of in vivo homologous recombination in S. cerevisiae it was demonstrated 
for gene cloning, plasmid construction and library creation since the late seventies of the last 
century [131-140] and was recently investigated by several groups for its potential for 
pathway engineering on a lab scale as well as for high throughput strain construction. Shoa et 
al. (2009) pioneered herein with the construction of three distinct functional pathways: a D-
xylose utilization pathway (9 kb, 3 genes), a zeaxanthin biosynthesis pathway (11 kb, 5 
genes) and the combination of both pathways (19 kb, 8 genes). All efforts resulted in 
assembly efficiencies of 70-100% on both, plasmids and chromosome [141]. This work was 
followed by others, for example by assembling nine different constructs that reached up to a 
total size of 21 kb and 95% correct assembly [111]. Despite the pathway assembly successes 
reached, incorrect and imprecise genome integration remained a problem for strain 
engineering programs. Low cloning efficiency was reached by occurrence of false positive 
clones, caused by re-circularization of plasmid backbones containing all requirements for 
selection and propagation [139, 140]. Additionally, the lengths of the homologous regions and 
the number and size of the assembled fragments were considered to be main factors for 
incorrect assembly of pathways [141-143]. Recent method development introduced the 
meganuclease I-SceI, which causes a double strand breakage at a specific recognition site 
within the targeted chromosomal locus [144, 145]. This breakage facilitated the integration of 
the assembled pathway and led to an radical efficiency improvement from 5% to 95% while 
assembling a ten-fragment 22 kb construct [146]. 
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Comparative studies have been performed to find out which method is most trustworthy for 
high-throughput cloning and integration [86, 95]. Therefore metabolic pathways with 
different sizes and amounts of inserts have been tested for efficiency. A clear conclusion was 
that homologous recombination and LCR results in a higher efficiency while comparing the 
correct assembly of 12 DNA parts than CPEC, Gibson cloning or others, independently of the 
amount or size of fragments and the final size of the metabolic pathway (Gibson isothermal 
assembly and CPEC showed a clear efficiency drop with 6 DNA parts or more) [86]. 
However, pathway construction and assembly is highly context dependent and might need 
different conditions in different situations. Additionally, not only final cloning efficiency is a 
relevant parameter, but also the efficiency of individual steps, which might differ from 
method to method. 
2.3.5. Different methods for chromosomal integration 
Once metabolic pathways have been assembled, the produced genetic fragments need to be 
transformed into the host and targeted towards the chromosomal positions of interest if stable 
expression is desired. The constructed fragments are therefore flanked by an up- and 
downstream recognition sequence [147]. A single or multicopy integration site can be 
selected for this purpose. As an example, in order to increase the copy number of the gene 
ws2, integrated into the S. cerevisiae chromosome, an integration cassette including the usage 
of a weak promoter and antibiotic selection was used for multiple rounds of transformation 
and strain evolution based on elevated antibiotic resistance [148-150]. The strain CB2I20, 
used in this research (paper II and paper IV), was evolved with stationary increased copy 
numbers of the ws2 gene to a final copy number of 6 [84]. Awareness about the importance of 
stable integration led to a recent research investigating 14 integration sites situated in between 
essential genes on chromosomes X, XI and XII which reduced the risk of intra-chromosomal 
recombinations [112]. The beta-galactosidase activity was measured during this comparison 
study for strains with the lacZ cassette integrated at the 14 integration sites [112] and the sites 
emerging were used for integration of the FAEEs producing pathway in paper III (see next 
chapter). 
2.4. Pathway assembly and expression experience during this work 
During this work several yeast strains have been constructed. At the starting point of the 
project, restriction-ligation cloning was still common practice (in our lab), and therefore I 
could follow the pathway engineering development from small towards large genetic 
fragments. At the same pace, different cloning strategies were established and therefore first-
hand experience demonstrated the difference between practical and theoretical cloning 
efficiency. During the same period a growing realization for the necessity of integration of 
genes and pathways into the genome was established.  
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Figure 2.1: Pathway assembly pipeline for linear chromosomal integration or plasmid construction [151]. 
While the yeast strains described in paper II expressed the genetic modifications from a 
plasmid based platform, in paper III all modifications were integrated into the yeast 
chromosomes. In agreement with the comparative studies that have been performed between 
different pathway assembly methods, homologous recombination has been most successful 
and was therefore used for the pathway construction pipeline is outlined as shown in figure 
2.1. Different than in some companies (definitely true for Amyris Inc), pathway construction 
in academia is, for several reasons, performed in more low throughput measures. Therefore 
most important argument for the application of methods is high efficiency but of course 
economics or speed also have to be considered. 
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Here, three different pathways (described in paper III) were constructed, assembled and 
integrated into the chromosomes of two different background strains, CEN.PK113-11C and 
JV04. The first pathway contained the gene ws2 and the strains carrying this integration 
cassette were used as a reference to the other strains. The next strains contained a pathway 
with genes ADH2, ALD6 and acsSEL641P in addition to the ws2 gene, while the last strains 
contained genes ACC1S1157A,S659A and ACB1 in addition to the previously named genes. The 
yeast strains that were constructed with help of linear chromosomal integration cassettes, 
carrying above described genes. All strains are listed in table 2.1 and all integration cassettes 
are shown in figure 2.2. Integration cassettes 1, 2 and 3 had a total length of respectively 
4.915 bp, 12.033 bp and 11.614 bp and where integrated into background strains 
chromosomal position XI-3 (cassette 1 and 2) and XI-5 (cassette 3)  of CEN.PK113-11C and 
JV04 with an efficiency of respectively 84%, 58% and 63%, 56% and 80%, 8%. 
 
Figure 2.2: Linear chromosomal integration cassettes assembled during this work [151]. 
Figure 2.1 shows the pathway assembly and integration pipeline which was used here. To 
construct the linear chromosomal integration cassettes, it was first necessary to amplify DNA 
bricks from a given set of plasmids by polymerase chain reaction (PCR). The primers used, 
were specifically designed with overhangs matching the end of the previous or next brick, 
respectively. Subsequently, a two-step fusion PCR [152] was performed to create the linear 
chromosomal integration modules if necessary. The different DNA modules formed the 
chromosomal integration cassettes (which included genome recognition sequences) and were 
transformed into S. cerevisiae, where they integrated into the chromosome by homologous 
recombination. Alternatively the recognition sites were homolog to the ends of a digested 
plasmid backbone and the constructed plasmids were purified and expressed in E. coli to 
reproduce (figure 2.1). 
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Table 2.1: List of strains used in this study (paper III) 
Strain Genotype or relevant characteristics† Engineered pathways* Source 
CEN.PK
113-11C MATa MAL2-8
c SUC2 ura3-52 his3-Δ1 - P. Kötter 
BdJ10 CEN.PK113-11C ws2 WS paper III 
BdJ11 CEN.PK113-11C ws2 ADH2n ALD6n acsseL641P WS + EDP paper III 
BdJ12 CEN.PK113-11C ws2 ADH2n ALD6n acsse
L641P 
ACC1S659A,S1157A ACB1n 
WS + EDP + 
FASP paper III 
JV04 MATa MAL2-8
c SUC2 ura3-52 his3-Δ1 are1Δ 
dga1Δ are2Δ lro1Δ pox1Δ - paper III 
BdJ13 JV04 ws2 WS paper III 
BdJ14 JV04 ws2 ADH2n ALD6n acsseL641P WS + EDP paper III 
BdJ15 JV04 ws2 ADH2n ALD6n acsse
L641P 
ACC1S659A,S1157A ACB1n 
WS + EDP + 
FASP paper III 
† native overexpressed genes are market with n, *Engineered pathways are defined as followed: WS: wax ester synthesis, 
EDP: ethanol degradation pathway, FASP: fatty acid synthesis pathway. 
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3. Yeast metabolism and fatty acid ethyl esters production 
 
S. cerevisiae is known as an industrial robust organism very suitable as a cell factory for 
production of bulk products. Since ancient times the organism has already been used for the 
fabrication of different products. For example, the production of bread was made possible due 
to the excretion of CO2 by yeast and beer and wine are bringing joy to people due to the 
alcoholic fermentation capacity of yeast. Since the 1980th, S. cerevisiae metabolism was 
adapted for maximized ethanol production followed by the development of metabolic 
engineering of the yeast to become a versatile production host for e.g. FAEEs. Therefore, in 
current yeast cell factories CO2 has mostly been considered to be a byproduct (and a loss in 
carbon). The above examples do not only demonstrate the metabolic engineering ability, but 
foremost the multi-functionality of the S. cerevisiae metabolism. This chapter, which has a 
focus on the production pathway of FAEEs in yeast, will therefore start with a short overview 
of the general metabolism of S. cerevisiae before deepening into the possibilities and its 
experimental outcomes of turning the alcohol producer into a FAEE cell factory.  
3.1. Central carbon metabolism in yeast 
S. cerevisiae consumes its substrates (foremost glucose), which function often as carbon as 
well as energy source and converts them through a fueling cascade of highly conserved and 
therefore finely tuned and tightly regulated chemical reactions towards the central metabolite 
precursor, pyruvate. The combined catalytic reactions of glycolysis and the pentose 
phosphate (PP) pathway, leading towards pyruvate are called the central carbon metabolism 
(figure 3.1). Whether, pyruvate is then further catabolized through the tricarboxylic acid 
cycle (TCA or Krebs cycle), for Gibbs free energy provision in the form of ATP or GTP, or 
converted into one of the 12 central metabolic precursors which enable the formation of yeast 
biomass by e.g. anabolic formation of amino acids, nucleotides or different lipids which form 
cellular membranes and are important for cellular functionality and energy storage. Formation 
of biomass is mostly coupled to a reduction of power and therefore an important function of 
the PP pathway is the production of reducing equivalents (mostly NADPH) which are 
required in biosynthetic reactions. Also, the individual defined metabolic pathways are not 
merely self-sufficient, but are connected by shared cofactors (ATP/ADP, NAD/NADH, 
NADP/NADPH and equivalents), metabolites and compartmentalization which results in a 
tight cellular regulatory effect. 
Because of the important role that the central carbon metabolism plays for the total yeast 
metabolism, the individual pathways are reviewed more in detail: Glycolysis describes the 
total of biochemical reactions in which glucose is broken down via the so called Embden-
Meyerhof-Parnas (EMP) pathway towards pyruvate. The EMP pathway can be described with 
the overall reaction: 
glucose + 2 ADP + 2 Pi + 2 NAD+ → 2 pyruvate + 2 ATP + 2 NADH + 2 H2O + 2 H+ 
(reaction 3.1) 
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Also the pentose phosphate (PP) pathway, consisting of an oxidative part and an anabolic 
function is involved in converting carbon from glucose into pyruvate. The overall reactions, 
divided into an anaplerotic and an oxidative function are described as follows: 
Anaplerotic PP function: 
5 glucose-6-P + 5 ATP → 6 ribose-5-P + 5 ADP + 4 H2O + 4 Pi  (reaction 3.2) 
Oxidative PP function: 
Glucose-6-P + 12 NADP+ + 7 H2O → 12 NADPH + 12 H+ + 6 CO2 + Pi         (reaction 3.3) 
However, while the description of above pathways is very brief, they can be reviewed more in 
detail in biochemistry or metabolic engineering textbooks [35]. The relative flux through the 
two pathways is dependent on the requirements of Gibbs free energy, reducing power in the 
form of NADH and NADPH and the resulting precursor metabolites. For example, the 
requirement of NADPH for the synthesis of large amounts of lipids might influence the 
distribution of the carbon flux through EMP- or PP pathways. 
S. cerevisiae is able to grow under aerobic as well as anaerobic conditions and can use 
multiple substrate sources, like glucose (C6), glycerol (C3) or ethanol (C2). During aerobic 
growth, the complete oxidation of pyruvate is performed inside the mitochondrion. The 
pyruvate dehydrogenase complex (PDC) catalyses the reaction in which pyruvate is converted 
to acetyl-CoA, which subsequently enters the TCA cycle in which it is reduced to CO2, H2O, 
FADH2 and NADH. The electron transport chain pumps protons (from reduced electron 
carriers generated by the TCA cycle) out of the inner mitochondrial membrane, creating a 
proton gradient over the membrane which is used by the ATP synthetase for the generation of 
ATP. This so called oxidative phosphorylation has a theoretical P/O ration of 2 in S. 
cerevisiae which lacks the system 1 electron in the transport chain for reduction of NADH 
and 1 for reduction of FADH. However, the operational P/O ratio is only about 1. To prevent 
replenishing of the TCA cycle metabolites (i.a. precursors needed for amino acids formation), 
the glyoxylate shortcut fulfills an essential anaplerotic role and in addition, the pathway is 
indispensible for cellular growth on C2 and C3 carbon sources (mostly ethanol, glycerol or 
acetate).   
In the yeast S. cerevisiae, the main fermentative pathway leads to ethanol (and small 
amounts of acetate and succinate) and is therefore also called alcohol fermentation. In S. 
cerevisiae, formation and consumption of NAD+ cofactor is balanced for sole formation of 
ethanol from glucose, however because of the production of metabolic building blocks for 
biomass formation, a net production of NADH occurs. To maintain the redox balance, 
glycerol is excreted and in consequence NADH is converted into NAD+. 
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Figure 3.1: Central carbon metabolism with MEP, PP pathway, TCA cycle and amino acid groups. 
3.2. Wax ester production 
Wild type S. cerevisiae lacks a suitable enzyme to perform a transesterification reaction to 
produce fatty acid ethyl esters (fatty acyl esters) from acyl-CoA and ethanol for the 
production of fuels (figure 1.2). Fortunately other organisms, mostly originating from the 
species of plants, mammals and bacteria, naturally express wax ester synthases and are 
therefore able to convert alcohols and fatty acids to acyl esters [153]. Wax esters are naturally 
formed for energy storage purposes, specific membrane functions or, in the case of plants, as 
a protective layer on top of the leaves. From an industrial perspective, wax ester molecules 
have been harvested for cosmetics, food additives and industrial lubricants. The energy 
storage ability, however, was not industrially explored until FAEEs became important for the 
biofuel industry as a biodiesel substitute.  
26 
 
Heterologous enzymes, like wax ester synthase in S. cerevisiae, are dependent on several 
factors i.a. promoter strength and transcriptional regulation, for successful and strong 
expression. Functionality of enzymes in their original hosts does not automatically result in 
functional enzyme expression in the cell factory host. Functionality of heterologous genes 
being expressed can result in large phenotypical differences to its endogenous host (see 
chapter 2) [80]. For example, the expression of jojoba embryo ester synthase did not show 
activity while expressed in S. cerevisiae [154]. Another wax ester synthase from bacteria did 
not only function as those but also as acyl-CoA:diacylglycerol acyltransferase (DGAT) and 
might therefore result in sub-optimal conversion into FAEEs [155].  
 
One of the first functional wax esters synthases expressed in S. cerevisiae was a WS/DGAT 
from A. calcoaceticus ADP1, which not only produced FAEEs but also accumulated TAGs 
and fatty acid isoamyl esters [32]. The highly unspecific acyltransferase activity of 
WS/DGAT demonstrated that the specificity of the enzyme towards its substrate and products 
is essential for a successful functioning of the enzyme to avoid unwanted side effects. Wax 
ester synthases originating from different bacteria were expressed and compared for their 
enzyme activity and affinity for different alcohol chain lengths in an E. coli cell factory, 
which was an obvious choice, because of its bacterial origin [33, 34, 78, 83, 156-160]. The 
atfA originating from A. baylyi and the wax ester synthases from, Marinobacter 
hydrocarbonoclasticus, Rhodococcus opacus, Mus musculus and Psychrobacter arcticus were 
characterized in a S. cerevisiae host [80]. All enzymes catalyzed a broad range of alcohol 
chain-lengths, but, preferred 1-dodecanol and 1-tetradecanol. However, in S. cerevisiae, the 
wax ester synthase (ws2) from M. hydrocarbonoclasticus did not only show the highest 
activity over the whole range of tested alcohol lengths, but also resulted in the largest 
production of FAEEs [80, 161]. The expression of ws2 resulted in a 1.3-fold larger FAEEs 
production than expression of the second best wax ester synthase (atfA) from A. baylyi [80]. It 
was shown that there were differences in functional expression of atfA, depending on which 
microbial host, E. coli or yeast was used [78, 154, 156, 162, 163].  
In this work, wax ester synthase (ws2) from M. hydrocarbonoclasticus was used to result in 
an optimum yield of FAEEs (paper II, paper III and paper IV) [151, 164]. However, yeast 
naturally provides ethanol (a two-carbon molecule) and saturated as well as unsaturated acyl-
CoAs of mostly 16 and 18 carbons. Keeping the alcohol preferences of ws2 in mind, the 
enzyme activity during ethanol consumption is only 16% compared to the enzyme activity 
during 1-tetradecanol consumption [80]. Therefore it is clear that the wax ester synthase 
requires enzyme engineering to adapt to the available substrates and microbial host 
environment. It will remain challenging to find a wax ester synthases which perfectly fit 
towards a S. cerevisiae host. Also the comparison of enzymes from different origins could 
contribute to understanding essential enzyme (regulatory) mechanisms and therefore it is 
important to enlarge the wax ester enzyme library from different hosts. A library of wax ester 
synthase could also point out differences in substrate and product preferences. Enzyme 
engineering was shown to result in more than 1000 fold improvements of enzyme activity in 
industry and therefore will also play an important role for the adaptation of the wax ester 
synthase in a heterologous environment. 
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3.3. Strategy one: Ethanol degradation pathway 
3.3.1. Central precursor acetyl-CoA 
One of the main challenges for the production of FAEEs in S. cerevisiae is the improvement 
of the production of cytosolic acyl-CoA. The main precursor for the fatty acid biosynthesis is 
acetyl coenzyme A (acetyl-CoA) and therefore the provision of acetyl-CoA is important for 
the improvement of the amount of acyl-CoA and subsequently the amount of FAEEs.  
 
Acetyl-CoA plays a central role in several cellular pathways and compartments, and is 
involved in regulatory mechanisms [165, 166]. Acetyl-CoA is found in the cytosol, the 
mitochondria, the peroxisome and the nucleus, but is not able to cross the organelle 
membranes. Acetyl-CoA also functions as a gateway for metabolic routes to many other 
biotechnologically valuable compounds, like polyhydroxybutyrates (PHB), isoprenoids, 
alkanes/olefins, waxes, polyketides, polyphenols or fatty alcohols and provision of the 
metabolite is therefore valuable as a platform stain. Due to the fact that the products needs to 
be excreted from the cells, there consists an interest to increase the production of acetyl-CoA 
in the cytosol [166, 167]. 
 
To ensure large amounts of cytosolic acetyl-CoA in S. cerevisiae and therefore an increase of 
the carbon flux towards cytosolic acetyl-CoA synthesis, the cytoplasmic pyruvate 
dehydrogenase (PDH) bypass, was metabolically engineered. The cytoplasmic PDH bypass 
converts pyruvate towards acetyl-CoA via acetaldehyde and acetate. The conversions involve 
the enzymatic activities of, respectively, pyruvate decarboxylase, acetaldehyde dehydrogenase 
and acetyl-CoA synthetase. Additionally, the major byproduct, ethanol, is formed from 
acetaldehyde by alcohol dehydrogenase. However, the reaction is reversible and Adh2 
converts ethanol into acetaldehyde and was therefore also target of the metabolic engineering 
strategy which was termed the ethanol degradation (EDP) pathway (see figure 3.2). This 
subchapter will discuss the reaction of the ethanol degradation pathway more in detail and 
will show the experimental outcome of engineering this pathway. 
3.3.2. Acetyl-CoA synthetase 
The conversion of acetate into acetyl-CoA is catalyzed by tightly regulated isoenzymes 
encoded by the genes ACS1 and ACS2 [168, 169] which are both cytosolically expressed 
[170-172]. It was shown that S. cerevisiae was not viable without ACS1 and ACS2 during 
growth on glucose and that both enzymes are subject to substrate regulation [168, 173]. On a 
transcriptional level, ACS1 is subject of glucose (and ethanol to a lesser extend) repression 
whereas absence of ACS2 prevented complete glucose repression [169, 173].  
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Figure 3.2: Ethanol degradation pathway 
As indicated before, Acs is subject to posttranslational regulation by acetylation in bacteria. 
However, it was reported that substituting proline for leucine at position 641 on Acs of 
Salmonella enterica prevents the acetylation of Acs and hereby keeps it in its active state 
[174]. Over-expression of heterologous acsSEL641P in S. cerevisiae resulted in a three times 
improvement of the enzyme activity compared to wild type ACS1 overexpression and in a 2 
times improvement in overexpression of the non-modified acsSE [175]. The improvement of 
enzyme activity indicated that the amino acid sequences around the acetylation site between 
Salmonella and yeast are well conserved and that posttranslational regulation of acetyl-CoA 
synthetase in yeast and Salmonella have similarities, although, similar regulation in yeast has 
not been identified yet [175]. Therefore, the heterologous acetyl-CoA synthetase variant, 
carrying an amino acid substitution, preventing inactivation by acetylation, from S. enterica 
encoded by acsSEL641P was overexpressed in paper II and paper III [164]. The overall 
reaction from acetate to acetyl-CoA can be described by the following reaction: 
 
Acetate + ATP + CoA → acetyl-CoA + AMP + PPi    (reaction 3.4) 
 
The conversion of ATP to AMP and diphosphate is a very unfavorable byproduct of the 
reaction and energetically equivalent to the conversion of two ATP molecules to two ADP 
and two phosphate molecules. It was estimated that such an energy expenditure is not 
compatible for process economics [176]. Recently, attempts have been targeting the 
circumvention this energy loss by the implementation of bacterial genes encoding acetylating 
acetaldehyde dehydrogenase (A-ALD) and pyruvate-formate lyase (PFL) in acs1Δ, acs2Δ S. 
cerevisiae strains [177]. Expression of ACS1 and ACS2 was successfully replaced by the 
heterologous pathways, however, both strategies do not directly fit within the FAEE 
producing yeast cell factory, because of the circumvention of NADPH production catalyzed 
by ALD6 (A-ALD) and the circumvention of ethanol production (needed as FAEE substrate) 
by the PFL pathway. 
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3.3.3. Acetaldehyde dehydrogenase 
The enzyme family of acetaldehyde dehydrogenases catalyzes the conversion of acetaldehyde 
to acetate. In the S. cerevisiae genome there are five genes known to encode the acetaldehyde 
dehydrogenase (ALD2, ALD3, ALD4, ALD5 and ALD6) [178]. The most relevant gene is 
ALD6 which is constitutively expressed in the cytosol, but is relocated to the mitochondrial 
outer surface upon oxidative stress. ALD6 encodes a Mg2+ dependent enzyme which uses 
NADP+ as cofactor [179, 180]. The full reaction catalyzed by acetaldehyde dehydrogenase 
looks as follows: 
Acetaldehyde + NADP+ + H2O → acetate + NADPH + 2 H+  (reaction 3.5) 
Not only ALD6, but also ALD2 and ALD3 are cytosolically expressed, however, Ald2 and 
Ald3 use NAD+ as a cofactor. Both enzymes are induced as response to ethanol or by stress 
but are repressed by glucose. The two K+ dependent acetaldehyde dehydrogenases, Ald4 and 
Ald5 are expressed in the mitochondrial compartment [181]. Ald5 is constitutively expressed 
whereas Ald4 is repressed by glucose. 
Next to production of NADPH in the oxidative part of the PP pathway is the conversion of 
acetaldehyde to acetate catalyzed by Ald6, the main reaction in wild type S. cerevisiae for 
producing the cofactor NADPH. (see figure 3.2). Grabowska et al. demonstrated this by 
constructing a S. cerevisiae mutant with deletions in ZWF1 (encoding glucose-6-phosphate 
dehydrogenase) and ALD6 (encoding cytosolic aldehyde dehydrogenase), which was not 
viable on glucose [35]. NADPH plays an important role for building the acyl-CoA chain and 
therefore it is essential to look into metabolic pathways producing this compound. An 
additional source of NADPH was identified during growth on lactate, namely cytosolic 
isocitrate dehydrogenase (Idp2) [182]. During this study glucose was used as a carbon source 
and the endogenous ALD6 was overexpressed to gain a larger cytosolic carbon flow towards 
acetyl-CoA in combination with NADPH production. Overexpression of cytosolic Ald2 
and/or Ald3 might belong to the future engineering options, however, the effect of the 
modification needs to be carefully evaluated, due to competitive interest with NADPH 
producing Ald6. 
3.3.4. Alcohol dehydrogenase 
During growth of S. cerevisiae on high concentrations of glucose, most glycolytic carbon is 
directed towards the production of ethanol from acetaldehyde, catalyzed by the tightly 
regulated alcohol dehydrogenase enzyme family. The production of ethanol is a direct effect 
of balancing the NAD+/NADH equilibrium. During growth with excess glucose, the TCA 
cycle and oxidative phosphorylation are repressed and ethanol functions as carbon sink. 
During the so called Crabtree effect [183, 184] there is also increased production of CO2, 
acetate, pyruvic acid and glycerol to maintain the redox balance [185, 186]. The reversible 
reaction from acetaldehyde to ethanol is catalyzed by alcohol dehydrogenase an enzyme 
family encoded by ADH1, ADH2, ADH3, ADH4 and ADH5. Adh1, Adh3, Adh4 and Adh5 
reduce acetaldehyde to ethanol during glucose fermentation while Adh2 catalyzes the reverse 
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reaction of oxidizing ethanol to acetaldehyde [88, 187-190]. The reaction is described as 
followed: 
 
Acetaldehyde + NADH + H+ ↔ ethanol + NAD+    (reaction 3.6) 
 
Acetaldehyde forms the branch point between carbon flux directed towards ethanol and 
directed towards cytosolic acetyl-CoA. Both ethanol and acyl-CoA are precursors for the 
production of FAEEs and therefore precise regulation of this branch point will be required to 
distribute the fluxes correctly without disturbance of the cellular redox balance. Complete 
deletion of the alcohol dehydrogenase enzyme family, resulting in depletion of ethanol is 
therefore not favored.  
 
The expression of the major alcohol dehydrogenase isoenzyme, ADH1, is required for the 
reduction of acetaldehyde to ethanol, which is the last step of the glycolytic pathway [191]. 
Although, ADH1 and ADH2 share about 90% sequence similarity, Adh2 differs in metabolic 
directionality due to differencse in substrate affinity and also shows a ten-fold lower Km value 
for ethanol than the other alcohol dehydrogenases [88, 192]. Therefore, when S. cerevisiaes 
metabolism changes to ethanol consumption after glucose depletion Adh2 is responsible for 
catalyzing the conversion of ethanol to acetaldehyde. The ADH2 promotor contains two cis-
acting elements (UAS1 and UAS2/CSRE) necessary for maximal ADH2 expression [193, 
194]. In absence of a fermentable carbon source, these sites are bound by transcriptional 
activators Adr1 and Cat8 [193, 195]. The presence of glucose down-regulates the 
transcriptional factors and consequently ADH2 is repressed several hundred-fold [193, 196]. 
ADH3 expresses an enzyme with 80% sequence similarity to ADH1 and ADH2, but it is 
located inside the mitochondrial matrix and is repressed in presence of glucose [189]. It was 
suggested that Adh3 was involved in the mitochondrial ethanol-acetaldehyde redox shuttle 
because of the demonstrated growth reduction of an adh3Δ mutant. Despite the fact that 
ADH4 encodes an enzyme, which is less related to the other alcohol dehydrogenase 
sequences, expression of the enzyme seems essential in case of malfunction of the major 
isoenzyme Adh1 [190]. All alcohol dehydrogenases are zinc dependent. 
3.3.5. Experimental outcome  
Summarized, the ethanol degradation pathway (figure 3.2) was employed to re-channel 
carbon flow towards the synthesis of acetyl-CoA (paper II). Therefore, ADH2 and ALD6 
encoding, respectively, alcohol dehydrogenase and acetaldehyde dehydrogenase were 
overexpressed together with the heterologous gene acsSEL641P encoding acetyl-CoA synthetase 
and ws2 from M. hydrocarbonoclasticus encoding wax ester synthase. The genes were under 
control of strong constitutive promoters (respectively, pHXT7, pPGK1, pTEF1 and pTEF1) 
and expressed from 2-micron plasmids [197]. However, expression of the four genes on a 2-
micron plasmid resulted in a plasmid size of 15.087 bp. Plasmid size as well as promoter 
strengths influence the stability of a plasmid and therefore the gene expression when 
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Table 3.1: List of plasmids used in metabolic engineering strategy 1 and 2. 
Plasmid name Genes Marker gene Source 
pIYC04 --- HIS3 [166] 
pBdJ01 ws2 HIS3 this study 
pICY09 ALD6, ADH2, acsSEL641P HIS3 [167] 
pBdJ02 ws2, ALD6, ADH2, acsSEL641P HIS3 this study 
pSP-GM2 --- URA3 - 
pSPB2N ws2 URA3 [84] 
pMPa xpKA, ack URA3 [198]@ 
pMPp xpKA, pta URA3 this study 
 
propagated in S. cerevisiae [199-201]. Therefore the four genes were also distributed over two 
different plasmids resulting in a smaller size of the individual plasmids (8.872 bp and 12.875 
bp). The strains and plasmids used for this strategy are listed in tables 3.1 and 3.2.  
The yield of FAEEs in four different strains (figure 3.3) was measured.  It could be observed 
that the introduction of a wax ester synthase resulted in a FAEE yield of 133 ± 113 μg 
gCDW−1. Up-regulation of ALD6, ADH2 and acsSEL641P, expressed from the same plasmid, led 
to a yield of 408 ± 270 μg gCDW−1, a 3-fold improvement compared with sole wax ester 
expression (p-value: 0.08). This strain showed a large variation of the FAEEs yield in the 
different clones measured, which might be caused by variations in copy number of the 
relatively large plasmid. Therefore, a similar strain was constructed, reducing the plasmid size 
by expressing the genes on two different plasmids. This strain, in which ws2 and the three 
genes ALD6, ADH2 and acsSEL641P were expressed from separate plasmids resulted in a 
FAEEs yield of 359 ± 128 μg gCDW−1. This modified strain showed a 2.7 fold improvement 
compared to sole expression of the wax ester (p-value: 0.03) and also showed a lower clonal 
variation than the strain expressing one large plasmid with all genes. 
 
Table 3.2: List of strains used in metabolic engineering strategy 1 and 2. 
Name Genetic background HIS3 based plasmid URA3 based plasmid 
Reference strain 
BdJref CEN.PK 113-11C pIYC04 (---) pSP-GM2 (---) 
Phosphoketolase strains 
BdJ01 CEN.PK 113-11C pBdJ01 (ws2) pSP-GM2 (---) 
BdJ02 CEN.PK 113-11C pBdJ01 (ws2) pMPa (xpkA, acK) 
BdJ03 CEN.PK 113-11C pBdJ01 (ws2) pMPp (xpkA, pta) 
BdJ04 CB2I20 --- pSP-GM2 (---) 
BdJ05 CB2I20 --- pMPa (xpkA, acK) 
BdJ06 CB2I20 --- pMPp (xpkA, pta) 
Ethanol degradation strains 
BdJ07 CEN.PK 113-11C pIYC04 (---) pSPB2N (ws2) 
BdJ08 CEN.PK 113-11C pBdJ02 (ws2, ALD6, ADH2, acsSEL641P) pSP-GM2 (---) 
BdJ09 CEN.PK 113-11C pIYC09 (ALD6, ADH2, acsSEL641P) pSPB2N (ws2) 
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Figure 3.3: FAEE yield (μg gCDW-1) of investigated S. cerevisiae strains expressing the ethanol degradation 
pathway. Biological triplicates of the strains were investigated. The experiment was performed twice and 
standard deviations are indicated. 
The ethanol degradation strategy has been applied for different engineering targets before. 
Chen et al. investigated the physiological effect of some major enzymes relevant for acetyl-
CoA metabolism on different carbon sources in S. cerevisiae [166]. The enzyme variant 
encoded by acsSEL641P was previously overexpressed together with ALD6, mainly responsible 
for the metabolic reaction to form acetate from acetaldehyde, in S. cerevisiae for high level 
production of amorphadiene [175]. This successful strategy had been improved by additional 
overexpression of ADH2 and ERG10 for the production of α-santalene which resulted in a 
1.75 times higher production than the reference strain and a 25% increase in titer compared to 
the strategy introduced by Shiba et al. [175]. The pull-push strategy, pushing the carbon flow 
down to acetyl-CoA by overexpression of ADH2, ALD6 and acsSEL641P and pulling it towards 
the product by overexpression of ERG10 was also applied in the production of 
polyhydroxybutyrate (PHB) in S. cerevisiae [202]. A 16-fold improvement of PHB 
production was detected compared to the reference strain. In this study, the wax ester synthase 
was used to pull the carbon flow towards production of FAEEs. Comparable to the previously 
performed studies described, we here found the improvement of product formation to be 3-
fold compared with the reference strain. This lower fold improvement might be caused due to 
regulation of downstream pathways leading to the formation of FAEEs. 
3.4. Strategy two: Heterologous phosphoketolase pathway 
The expression of heterologous pathways in S. cerevisiae could establish (a chain of) new 
metabolic reactions or improve endogenous reactions and is therefore of interest to metabolic 
engineering. For the improvement of fatty acid derived products in S. cerevisiae, several 
heterologous pathways have been implemented including pyruvate formate lyase (PFL) or 
acetylating aldehyde dehydrogenase (A-ALD) [177, 203, 204]. A metabolic engineering 
landmark was recently reached with the implementation of a pyruvate dehydrogenase 
complex from Enterococcus faecalis, which circumvented energy loss of cytosolic acetyl-
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CoA synthase [176]. In strategy two of my thesis project (paper II) the phosphoketolase 
(PHK) pathway was investigated for the production of FAEEs. 
The redox co-factor NADPH is required for formation of acyl-CoAs, which typically has 7 
rounds of reaction cycles including two reduction steps, each requiring NADPH [205]. The 
most important NADPH source in S. cerevisiae is assigned to the oxidative part of the pentose 
phosphate pathway, and therefore, a metabolic pathway leading towards the synthesis of 
acetyl-CoA by rechanneling carbon flow via the PPP was investigated. The phosphoketolase 
pathway was described previously as potential alternative carbon route for different 
industrially relevant metabolites due to the increase of acetyl-CoA production with NADPH 
as co-product [198, 206, 207]. The carbon flow leading towards the PHK pathway starts with 
the conversion of glucose to glucose-6-phosphate in the EMP pathway followed by 
conversion of glucose-6-phosphate in three reactions into ribulose-5-phosphate in the 
oxidative part of the pentose phosphate pathway. Byproducts during these reactions are two 
moles of NADPH and one mole of CO2 per mole of glucose. The next metabolite in the 
pathway, xylulose-5-phosphate, represents the precursor of the PHK pathway as it can be 
converted to acetyl-phosphate and glyceraldehyde-3-phosphate.  
 
xylulose-5-P + Pi → acetyl-P + GAP    (reaction 3.7) 
This reaction is catalyzed by xylulose-5-phosphate phosphoketolase encoded by xpkA in 
Aspergillus nidulans, but the gene is also expressed in other organisms [208]. During the 
second step of the PHK pathway, acetyl phosphate can either directly be converted into 
acetyl-CoA or indirectly with acetate as intermediate. Direct conversion of acetyl phosphate 
into acetyl-CoA in Bacillus subtilis is catalyzed by phosphotransacetylase encoded by the 
gene pta [209].  
 
acetyl-P + CoA → acetyl-CoA + Pi    (reaction 3.8) 
The formation of acetate and ATP from acetyl phosphate is performed by acetate kinase, 
encoded by the gene ack in A. nidulans [210, 211]. The PHK pathway is shown in Figure 3.4. 
 
acetyl-P + ADP + Pi → acetate + ATP   (reaction 3.9) 
 
The PHK pathway was first reported in heterofermentative and facultative homofermentative 
lactic acid bacteria, in bifidobacteria and sporadic in other microorganism, like xylose 
fermenting yeasts [212]. It has been demonstrated that S. cerevisiae has the ability to 
functionally express phosphotransacetylase from B. subtilis as well as phosphoketolase and 
acetate kinase from A. nidulans [198, 213]. Although, the above mentioned microbial sources 
were used in these studies, several other microbial sources for enzymes of the different 
reactions are known and were also tested in a S. cerevisiae host [208].The fact that more 
NADPH is formed when glucose is metabolized via the PP pathway instead of the EMP 
pathway makes the combination of the PP pathway and the PHK pathway an interesting 
alternative for production of FAEEs. The demand of NADPH for lipid synthesis might create 
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the driving force for carbon to flow through the PHK pathway. It was demonstrated that 
glucose catabolism through the PHK pathway would improve the net NADPH supply for 
FAEE production. 
 
Figure 3.4: Overview of the phosphoketolase pathway. xpkA and ack are originally from A. nidulans while pta is 
from B. subtilis. 
3.4.1. Experimental outcome: 
During this work (paper II) several strains were constructed to test the expression of the PHK 
pathway genes in S. cerevisiae for the production of FAEEs (the strains are listed in table 
3.2). Therefore, two genes, xpkA and ack, both descending from A. nidulans, were expressed 
to catalyze, respectively, the conversion of xylulose-5-phosphate to acetyl phosphate and 
glyceraldehyde-3-phosphate and acetyl phosphate to acetate with the gain of one ATP. A 
second strain was constructed, in which the gene pta from B. subtilis replaced ack. Pta 
converts acetyl phosphate directly to acetyl-CoA. Both strains were compared with a strain 
containing solely the ws2 gene and to a reference strain, containing the empty reference 
plasmids. Figure 3.5 shows the quantification of total FAEEs of the described S. cerevisiae 
strains. The expression of xpkA, ack and ws2 resulted in a FAEE yield of 28 ± 3.5 μg gCDW−1 
which is 1.5 times higher than for the strain only expressing ws2. However, the difference 
between the two strains showed insufficient statistical significance (p-value: 0.10). The 
expression of xpkA, pta and ws2 led to a FAEE yield of 105 ± 30 μg gCDW−1 which was 5.7 
fold higher than the strain with only ws2 expression (p-value: 0.03) and a 3.7 times higher 
FAEE yield than the strain expressing xpkA, ack and ws2 (p-value: 0.05). However, due to the 
relatively low yield of the strains described above and because of presumed fluctuating 
plasmid stability during repetitive experiments, the PHK pathway was also expressed in strain 
CB2I20, a strain with multiple chromosomal ws2 integrations [84]. These strains are listed in 
table 3.2. It was also hypothesized that multiple expression of the ws2 gene might contribute 
to a stronger carbon-pull through the PHK pathway. Expression of xpkA and pta in strain 
CB2I20 resulted in 4670 ± 379 μg gCDW−1 (p-value: 0.02), a 1.6 fold higher yield of FAEEs 
compared to the reference strain CB2I20, whereas the expression of xpkA and ack in CB2I20 
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improved the final yield of FAEEs to 5100 ± 509 μg gCDW−1 (p-value: 0.01), which is a 1.7 
times improvement compared to the reference strain (figure 3.6). It could also be observed 
that the production levels of FAEEs in strains BdJ04-BdJ06 were stable and reproducible. 
 
Figure 3.5: FAEE yield (μg gCDW-1) of investigated S. cerevisiae strains expressing a heterologous PHK 
pathway. Biological triplicates of the strains were investigated. The standard deviations are indicated. 
In this study, it was found that expression of the phosphoketolase pathway in S. cerevisiae 
could re-channel carbon flux through the oxidative part of the PP pathway, via the PHK 
pathway, towards the precursors acetyl-CoA and malonyl-CoA for synthesis of acyl-CoA. As 
a consequence, two molecules of the NADPH are being produced for each sugar molecule 
passing through the PP pathway. As was demonstrated earlier by Papini et al. the expression 
of genes xpkA and ack showed a functional carbon flux through the PHK pathway and as 
shown in this study the expression of genes xpkA, ack and ws2 resulted in a yield of FAEEs 
50% higher than in a strain not expressing the PHK pathway [198]. It was also shown that the 
expression of xpkA and ack resulted in an improved polyhydroxybutyrate (PHB) producing 
strain [207]. Papini et al. could not demonstrate the functionality of the PHK pathway using 
phosphotransacetylase gene pta (instead of ack), which would result in a direct conversion of 
acetyl phosphate to acetyl-CoA. However, in their study they did not insert a pull of acetyl-
CoA for a specific product, whereas our result clearly shows that expression of this enzyme 
combination results in improved FAEEs production (minimal 60% improvement), which 
strongly indicates that the enzymes are active.  
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Figure 3.6: FAEE yield (μg gCDW-1) of investigated S. cerevisiae strains containing multiple ws2 chromosomal 
integrations and expressing a heterologous PHK pathway. Triplicate clones of each strain were investigated 
(described by 1, 2 and 3). The experiment was performed twice (light and dark columns) and standard deviations 
are indicated. 
3.5. Strategy three: Integration of metabolic engineering strategies 
Many different metabolic engineering strategies have been employed to improve S. cerevisiae 
cell factories for fatty acid derived products. However, the combined effect has never been 
investigated for the production of FAEEs. An important engineering target is shaped by the 
two reactions, acetyl-CoA carboxylase and fatty acid synthase, which convert acetyl-CoA into 
acyl-CoA chains. In paper III, a combination of multiple successful FAEE engineering 
strategies was chosen to be stably (over)expressed in S. cerevisiae.  
3.5.1. Acetyl-CoA carboxylase 
In yeast, S. cerevisiae, malonyl-CoA is formed from acetyl-CoA by acetyl-CoA carboxylase 
[81, 151, 214] and together the two molecules form the precursors for the ‘activated’ form of 
fatty acid, the acyl-CoA chain. The reaction does not only form the entrance to the fatty acid 
synthase pathway, but is therefore also considered to function as a ‘gate keeper’ of the flux 
into this pathway. 
acetyl-CoA + ATP + HCO3- → malonyl-CoA + ADP + Pi + 2 H+  (reaction 3.10) 
The reaction, in which malonyl-CoA is produced at the expense of ATP and carbon dioxide, 
occurs in two different compartments. The mitochondrial enzyme is encoded by HFA1 
whereas the cytosolic enzyme is encoded by ACC1. Acc1 is a multifunctional enzyme whose 
activity is controlled by biotin availability as it has been reported that reduced levels of this 
vitamin affect the synthesis of fatty acids [215]. The specific molecular composition of acyl-
CoA and its downstream products directly regulate genes of the fatty acid synthesis pathway 
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via feedback inhibition and by positive (Ino2p and Ino4p) and negative (Opi1p) regulatory 
factors [205, 216-218]. 
It is thought that Snf1-dependent phosphorylation attenuates the activity of acetyl-CoA 
carboxylase and maintains the appropriate acyl-CoA chain length distribution and the ratio of 
C16 versus C18 acyl-CoAs [219, 220]. In S. cerevisiae, Snf1 is involved in regulation of 
cellular stress response, pseudohyphal growth, aging, ion homeostasis and in regulation of 
specific pathways like gluconeogenesis, glyoxylate cycle, oxidation of fatty acids and 
therefore it was not possible to eliminate this regulatory factor [70]. However, to prevent post-
translational regulation of Acc1 by phosphorylation in S. cerevisiae, amino acid 1157, 
verified as target by phosphoproteome analysis [221], and amino acid 659 (part of a potential 
phosphorylation recognition motif (Hyd-X-Arg-XX-Ser-XXX-Hyd) for Snf1) [222] both 
serines have been replaced by amino acid alanine [81, 216, 223]. Despite the fact that a higher 
content of free fatty acids (and related molecules) was yielded by the latter replacement [81] it 
was never proven that the acc1S1157A,S659A was more active that its acc1 or  acc1S1157A 
counterpart.   
3.5.2. Fatty acid synthase 
The formation of acyl-CoA is catalyzed by fatty acid synthase, encoded by FAS1 and FAS2 
both active in multiple compartments, including the cytosol. While the main function of 
mitochondrial fatty acid formation is the provision of lipoic acid co-factor for the pyruvate 
dehydrogenase complex [224], the majority of fatty acids are provided in the cytosole where 
they have a large (energy) storage and therefore they are more relevant for engineering 
applications [225]. Fas1 and Fas2 are multi-subunit proteins with all required enzyme 
activities for building long chain fatty acids from acetyl-CoA and malonyl-CoA [226, 227]. 
As shown in figure 3.7, acyl-CoA formation is established as followed: Acetyl-CoA is loaded 
to the acyl-carrier protein (ACP) by acyltransferase (AT), followed by repetitive elongation 
(of on average seven rounds) of the acyl-CoA chain by two carbon molecules a time, until a 
maximum of 16 carbons is reached [228]. The elongation cycle starts with loading a molecule 
of malonyl-CoA and sequential catalytic steps of β-ketoacyl-ACP synthesis, β-ketoacyl-ACP 
reduction, β-ketoacyl-ACP dehydration and enoyl-ACP reduction. Two molecules of NADPH 
are converted to NADP+ + 2 H+ during the reducing steps [229]. During the final step, acyl-
ACP and malonyl-CoA are transformed by malonyl transacylase (MPT) to form acyl-CoA 
and the activated malonyl-ACP, which is necessary for initiating the next acyl-CoA synthesis. 
More extensive reviews of the process of fatty acid synthesis and industrially relevant fatty 
acid derived products are reviewed elsewhere [214, 230]. 
The Fas1 and Fas2 enzyme system is tightly regulated by several cellular layers [205, 231, 
232]. Due to the fact that the Fas1 and Fas2 are large enzymes with multiple subunits, 
communication between the different catalytic centers is required to enable the movement of 
the growing acyl-CoA chain. Both, FAS1 and FAS2 are constitutively activated by general 
transcription factors Rap1, Abf1 and Reb1 and similar to ACC1, both enzymes are activated 
by Ino2p and Ino4p [233-235]. The two enzymes also regulate each other as Fas1 controls 
FAS2 mRNA levels [236]. Several engineering efforts have been performed to deregulate the 
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FAS1 control and to increase acyl-CoA derived products. A recent attempt, in which 
transcriptional factor RPD3, a negative regulator of phospholipid metabolism, was deleted, 
enabled an improved production of fatty alcohols 1.6- to 2.7-fold [237]. 
 
Figure 3.7: Overview of fatty acid biosynthase in S. cerevisiae of fatty acid biosynthase in S. cerevisiae: 1) 
acetyl-CoA carboxylase, 2) malonyl/palmitoyl transferase, 3) ketoacyl reductase, 4) dehydratase, 5) enoyl 
reductase and 6) keto acyl synthase. 
Once the acyl-CoA chain is formed, it is bound by acyl-CoA binding protein (Acb1) which 
plays an important role for facilitating intracellular transport of acyl-CoA esters to the 
membrane of the endoplasmic reticulum and lipid bodies for phospholipid and TAG 
biosynthesis [238]. Additionally, it was reported that Acb1 had an attenuating effect on the 
negative feedback mechanism of acyl-CoAs on fatty acid synthase, acetyl-CoA carboxylase 
and long chain acyl-CoA synthetase [239-241].  ACB1 has therefore been targeted for two 
opponent metabolic engineering strategies. Both the overexpression of the ACB1 gene [84] to 
improve the attenuation of the negative feedback loop as well as its deletion to prevent 
transport of acyl-CoA towards unwanted cellular locations [82] resulted in a positive effect on 
FAEE production. It remains unclear which engineering strategy concerning ACB1 resulted in 
the best outcome for FAEE production. 
However, naturally several different pathways use acyl-CoA as a substrate for the formation 
of triacylglycerides (TAGs; storage lipids), sterol esters, phospholipids (membrane structure 
and function), sphingolipids or free fatty acids. Additionally, acyl-CoA can be degraded to 
acetyl-CoA by the β-oxidation pathway. It becomes clear that acyl-CoA competition plays a 
major role while implementing a new acyl-CoA consuming pathway, for industrial products 
like FAEEs, alkanes/alkenes, fatty alcohols and others.  
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Therefore the question rose whether or not pathways competing with wax ester conversion 
could be disrupted. Natural acyl-CoA derived products with cellular functionality for 
trafficking and for membranes could not be circumvented; however the acyl-CoA competing 
pathways leading towards triacylglycerols (TAGs), steryl esters (both serving as storage 
lipids) and the β-oxidation pathway, could be disrupted to prevent energy loss for the 
production of FAEEs. Therefore, these pathways have previously been inactivated by 
disruption of DGA1, LRO1 (both encoding diacylglycerol acyltransferases), ARE1, ARE2 
(both encoding sterol acyltransferases) and POX1 (encoding acyl-CoA oxidase) [32, 79]. The 
knock-out strain was used to express a wax ester synthase from M. hydrocarbonoclasticus 
(ws2) [80] and resulted in a yeast strain with the inability to synthesize storage lipids and an 
FAEE production of 17.2 mg/l [79].  
Table 3.3: List of strains used in metabolic engineering strategy 3. 
Strain Genotype or relevant characteristics† Engineered 
pathways* 
Source 
CEN.PK
113-11C MATa MAL2-8
c SUC2 ura3-52 his3-Δ1 - P. Kötter 
BdJ10 CEN.PK113-11C ws2 WS This study 
BdJ11 CEN.PK113-11C ws2 ADH2n ALD6n acsseL641P WS + EDP This study 
BdJ12 
CEN.PK113-11C ws2 ADH2n ALD6n acsseL641P 
ACC1S659A,S1157A ACB1n 
WS + EDP + 
FASP This study 
JV04 MATa MAL2-8
c SUC2 ura3-52 his3-Δ1 are1Δ 
dga1Δ are2Δ lro1Δ pox1Δ - This study 
BdJ13 JV04 ws2 WS This study 
BdJ14 JV04 ws2 ADH2n ALD6n acsseL641P WS + EDP This study 
BdJ15 
JV04 ws2 ADH2n ALD6n acsseL641P 
ACC1S659A,S1157A ACB1n 
WS + EDP + 
FASP This study 
† native overexpressed genes are market with n, *Engineered pathways are defined as followed: WS: wax ester 
synthesis, EDP: ethanol degradation pathway, FASP: fatty acid synthesis pathway. 
3.5.3. Experimental outcome 
Here (paper III), a combination of multiple successful FAEE engineering strategies was 
investigated by stable (over)expression in S. cerevisiae. Therefore, the endogenous alcohol 
dehydrogenase (encoded by ADH2), acetaldehyde dehydrogenase (encoded by ALD6) and a 
heterologous acetyl-CoA synthetase variant  from S. enterica insensitive to regulation by 
acetylation (encoded by acsSEL641P) were over-expressed for the improvement of the supply of 
the precursor acetyl-CoA and cofactor NADPH [164]. This was combined with 
overexpression of ACC1S1157A,S659A and ACB1 to increase the acyl-CoA pool [81], which was 
converted into FAEEs by wax ester synthase Ws2 [80]. These stable chromosomal 
integrations were introduced in wild type S. cerevisiae as well as in a mutant strain lacking 
acyl-CoA competitive but non-vital pathways (are1Δ dga1Δ are2Δ lro1Δ pox1Δ) [79]. The 
constructed strains are described in table 3.3 and figure 3.8 gives an overview of the modified 
genes in the metabolic pathway. 
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Figure 3.8: Overview of metabolic engineering approaches of FAEE in S. cerevisiae. Blue arrow indicates 
overexpressing of the gene. This scheme is simplified and does not show co-factors or compartmentalization. 
The expression of chromosomal integrated ws2 in a CEN.PK113-11C background strain 
resulted in a production of 261 ± 57 μg total FAEEs gCDW-1. Additional expression of 
ADH2, ALD6 and acsSEL641P resulted in an FAEE production of 463 ± 77 μg total FAEEs 
gCDW-1 and further chromosomal integration of ACC1S1157A,S659A and ACB1 resulted in a 
strain producing 570 ± 130 μg total FAEEs gCDW-1. Compared to the expression of ws2 
alone, the latter two strains improved the yield 1.8 fold and 2.2 fold (see figure 3.9 A). The 
additional expression of ACC1S1157A,S659A and ACB1 improved the FAEE yield 1.2 fold. 
 
Chromosomal overexpression of ws2 inside a background strain with disrupted conversion of 
free fatty acids towards sterol esters, triacylglycerides and acetyl-CoA via the β-oxidation 
pathway resulted in 506 ± 58 μg total FAEEs gCDW-1. In the same strain, additional 
expression of genes ADH2, ALD6, acsSEL641P, yielded 797 ± 69 μg total FAEEs gCDW-1, 
which was a 1.6 fold improvement. The strain in which the strategies of expressing ws2, 
ADH2, ALD6, acsSEL641P, ACC1S1157A,S659A, ACB1 and eliminating the fatty acid competing 
pathways were combined, resulted in a yield of 1072 ± 160 μg total FAEEs gCDW-1 which 
was the highest FAEE yield detected here (figure 3.9 B). This most extensively engineered 
strain resulted in a 4.1 fold improvement of the FAEEs yield compared with the reference 
strain, in which S. cerevisiae only carried the ws2 gene. 
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Overall, overexpression of genes in combination with the disruption of the acyl-CoA 
competing pathways resulted in an 1.85 ± 0.11 fold improvement in FAEEs production 
compared with the respective counterpart strains based on CEN.PK113-11C (figure 3.9 A and 
3.9 B). However, the mutant strains without these acyl-CoA competing pathways resulted in a 
lower final biomass concentration after substrate depletion (data not shown). Therefore, while 
comparing the titers of the different strains, the first strains showed titers of, respectively, 1.3 
± 0.3, 2.3 ± 0.4 and 3.5 ± 0.8 mg l-1 (figure 3.9 C) versus FAEEs titers of the latter strains of 
respectively 2.0 ± 0.2, 2.2 ± 0.2 and 4.4 ± 0.7 mg l-1 (figure 3.9 D).  
FIGURE 3.9: FAEE yields of engineered strains based on background CEN.PK.113-11C (A) and background 
strain JV04 with disrupted conversion of acyl-CoAs towards sterol esters, triacylglycerides and acetyl-CoA via 
the β-oxidation pathway (B) as well as FAEE titers (g/l) of FAEEs producing strains based on background 
CEN.PK113.11C (C) and JV04 (D). The distribution of acyl moieties in the different FAEEs pools is indicated 
by the color code. Results represent the average ± standard deviation of duplicate performed shake flask 
experiments with biological triplicates [151]. 
3.5.3.1. Chain length distribution 
All constructed strains contain a wax ester synthase, which catalyzes the transesterification 
reaction that converts ethanol and acyl-CoA into FAEEs. In S. cerevisiae, the predominant 
fatty acids are sixteen and eighteen carbon atoms long and exist in their saturated form as well 
as in their mono-unsaturated form [216]. The most obvious change in FAEEs chain length 
distribution occurred for unsaturated 16:1 FAEEs after elimination of the fatty acid competing 
pathways (figure 3.9). Before the deletion the share of unsaturated 16:1 FAEE was 27 ± 3.5 % 
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whereas after the deletion 56 ± 6.5 % was unsaturated 16:1 FAEE. This increase is almost 
solely responsible for the improved production of total FAEEs. On the other hand, the fraction 
of saturated 16:0 FAEE and saturated 18:0 FAEE in the same strains were reduced from, 
respectively, 24 ± 1 % to 14 ± 3 % and from 20 ± 1% to 8 ± 2 %. No significant difference for 
the 18:1 unsaturated FAEE content was detected. Also the implementation of genes ADH2, 
ALD6 and acsSEL641P or ACC1S1157A,S659A and ACB1 did not show any significant difference for 
the distribution of the carbon-chain length (see figure 3.9).  
3.6. Overview of the metabolic engineering strategies 
During this chapter, three different metabolic engineering strategies to convert S. cerevisiae 
from ethanol producer into a FAEE producing cell factory were discussed. First, two different 
strategies, the ethanol degradation pathway and the heterologous phosphoketolase pathway 
were tested in S. cerevisiae.  
The overexpression of genes ADH2, ALD6 and acsSEL641P in combination with ws2 from M. 
hydrocarbonoclasticus showed a 3-fold improvement compared to sole expression of the wax 
ester (p-value: 0.03). This lower fold improvement (compared to the application of the 
strategy for the production of other compounds) might be caused due to regulation of 
downstream pathways leading to the formation of FAEEs. 
Also the expression of ack from A. nidulans or pta from B. subtillis combined with expression 
of xpkA from A. nidulans and ws2 from M. hydrocarbonoclasticus represents a successful 
strategy for increasing FAEEs production by S. cerevisiae. The maximal improvement was 
achieved by the combined expression of xpkA, pta and ws2  which led to a FAEE yield of 105 
± 30 μg gCDW−1 which was 5.7 fold higher than the strain with solely ws2 expression (p-
value: 0.03). 
Further the results from a combination of several engineering strategies, which were stably 
integrated into the S. cerevisiae chromosome was discussed here. This most extensively 
engineered strain, with overexpression of genes ADH2, ALD6 and acsSEL641P or 
ACC1S1157A,S659A, ACB1 and ws2 and simultaneous deletion of acyl-CoA competitive but non-
vital pathways (are1Δ dga1Δ are2Δ lro1Δ pox1Δ) resulted in stable expression and a 4.1 fold 
improvement of the FAEEs yield compared with the reference strain, in which S. cerevisiae 
only carried the ws2 gene. This strain represents a very good starting point for further 
engineering, e.g. evaluation of the effect of increased expression of the wax ester synthase, 
which is likely to be limiting production by the engineered strains. 
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4. Phenotypic characterization  
The design of a new cell factory, irrelevant whether or not constructed by rational 
modifications or by evolutional adaptations, will result in a new phenotype of the cell factory. 
It is the task of the researcher to understand the new cellular behavior, to compare it with the 
expectations and to connect the outcomes of different analyses and to draw conclusions. In 
that sense, fundamental knowledge of cellular behavior is a requirement for applied 
engineering strategies. This chapter will discuss several different analytical methods used for 
gaining insight into the (global) behavior of microbial cell factories. 
4.1. Quantification of batch cultivations 
The aim that is mostly pursued for microbial cell factories is to reach high product formation, 
within a short amount of time and inside a small reaction volume. These parameters are of 
crucial importance for industrial process economics and therefore the main engineering 
targets of cell factories. In order to access the performance of a cell factory it is important to 
quantitatively access its titer, rate and yield, and the simplest way to obtain this quantitative 
information for cell factories is the use of a so called ‘black-box’ model. In this case, a black-
box is a system in which it is precisely defined what goes into the microbial cell factory and 
accurately measured what is excreted from the system, while the microbial cells are only 
considered as self replicating catalysts. Mass balances are therefore indispensable tools 
offering valuable information on reaction rates such as biomass formation, substrate uptake or 
product formation rates, but also for example, enable the determination of unknown metabolic 
products. The same way, not only carbon balances, but also redox or electron balances can be 
formed. 
 
A typical batch growth of S. cerevisiae, consists of a glucose consumption phase, a diauxic 
shift in which metabolism switches from glucose to ethanol consumption, followed by an 
ethanol consumption phase. The growth on each of the substrates is characterized by a lag, 
acceleration, exponential, deceleration and stationary phase (see experimental data figure 4.3). 
An important parameter is the speed of growth of the microbe. With sufficient nutrients, 
cellular growth is exponential. The specific growth rate is described by μ (h-1) and in a closed 
batch system it equals 
 
μ ൌ ଵୡ౮
ୢୡ౮
ୢ୲       (equation 4.1) 
with cx being the biomass concentration. And the doubling time td (h), which also resembles 
the generation time τ can directly be derived from integration of reaction 4.1 
ݐௗ ൌ ୪୬ଶஜ ൌ
଴Ǥ଺ଽଷ
ஜ       (equation 4.2) 
The specific growth rate of an organism is dependent on the nutrient availability, the 
assumption that one substrate is limiting, as formulated by Monod (1949) results in: 
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ߤ ൌ Ɋ୫ୟ୶ ୡ౩ୡ౩ା୏౩     (equation 4.3) 
 
Here, cs is the substrate concentration of the limiting substrate in the environment (g L-1), μmax 
the maximum specific growth rate (h-1) and Ks is the limiting substrate concentration at which 
the specific growth rate is half its maximum value. Notably, the Ks value in the Monod model 
does not exactly represent the saturation constant for substrate uptake, but only an overall 
saturation constant for the whole growth process. However, Ks values mostly do not differ 
significantly from Km values of the enzymes involved in substrate uptake, because substrate 
uptake is often closely connected to the control of substrate metabolism. During the 
exponential growth phase of a batch cultivation it can be assumed that Ks << cs, and therefore, 
during exponential growth the following equation is valid 
 
ߤ ൌ ߤ௠௔௫       (equation 4.4) 
 
To obtain the best possible experimental outcome, the μmax can be calculated by linear 
regression and least square fitting of ln(cx) over time during the exponential growth phase.  
Mass balances for substrate (s) and product (p) can be set the same way as described for 
biomass (x): 
െୱ ൌ ଵୡ౮
ୢୡ౩
ୢ୲       (equation 4.5) 
 
୮ ൌ ଵୡ౮
ୢୡ౦
ୢ୲       (equation 4.6) 
 
in which cs and cp are the concentrations of substrate and product, respectively.  
Next to the microbial growth rate, one of the most important parameters is the amount of 
product produced per amount of substrate, the yield: Ysp. Yield can be assigned to each 
compound in the process and is performed depending on the piece of information necessary 
for process improvement (for example Yxp in kg/kg but mostly mole/mole or Cmol/Cmol). 
The theoretical yield of a process, compared to the current process yield, demonstrates the 
available capacity for improvement of the process. For a specific time in a process the yield 
of, in this case substrate on product, can be described as 
 ௦ܻ௣ ൌ ୰౦ି୰౩ ൌ
୯౦
ି୯౩   (equation 4.7) 
In the examples above, the rates specific to biomass are indicated by q (Cmol p (Cmol s)-1 h-
1). However, as described in equation 4.7, rates of conversion can also be indicated per 
volume: r (kg m-3 h-1 or Cmol m-3 h-1) which describes the rate of utilization of the reactor.  
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4.2. Fermentation mode 
A microbial cell factory can be characterized well in fully controlled fermentors, but such a 
process is time consuming and expensive. Therefore, microorganisms are mostly cultured in 
different ways. A fast, uncontrolled and imprecise method of growing and screening cellular 
behavior is performed with, for example, shake flasks in which only constant mixing and 
temperature of the culture is ensured. In industry, large numbers of modified strains have to 
be tested and to speed up the process of strain screening, the volume (and consequently the 
costs) is scaled down to less than a milliliter with systems like for example the commercial 
BioLector® (m2p-labs, Baesweiler, Germany). This and similar systems ensure a larger 
throughput of samples and enable the monitoring of (few) parameters, but are not able to react 
to changes in the fermentation broth (like pH). Neither is it possible to control culture modes 
differently than batch-cultures or to take (larger) samples [242]. Additionally, some of the 
measured parameters provide crucial information but lack precision and accuracy demanded 
for drawing calculated conclusions. Therefore, it is challenging to create high-through-put 
methods of cell culturing which trustfully transfer knowledge of the microbial physiology 
without missing out data. 
However, the physiological data and the ability to regulate the parameters in the reactor are 
important reasons for investing time and money into controlled cultivation. Mainly three 
different cultivation modes (many more exist), the batch, fed-batch and chemostat reactors are 
used (see figure 4.1). During batch, all nutrients are available from the beginning of the 
cultivation and the process will continue until the substrate is depleted or growth is inhibited 
by external factors. A fed-batch is started like a batch reactor but will increase the 
fermentation volume with controlled inflow of substrates so that the maximum product 
formation will be yielded when the capacity of the reactor is reached. The rate of nutrient 
addition can depend on different parameters of regulation. A chemostat culture or continued 
culture, has a constant inflow rate of nutrients which equals the outflow rate of fermentation 
broth, while the reactor volume is constant. The rate and composition of the inflow can be 
regulated and therefore parameters like the specific growth rate or the limitation of nutrients 
can be influenced. 
In large scale industrial set-ups most processes are run in a batch or fed-batch mode despite 
the advantages of continuous cultures. In industrial practice, the latter system is tackled down 
by the fact that a continuous system is sensitive to contamination by other, faster growing 
microbes. However, on a lab scale, a chemostat provides a valuable basis for investigating 
reactor and microbial cultivation properties because of the fact that the process remains in a 
pseudo steady state. For this reason it is the ideal state to measure the difference between 
different culture conditions. More information can be found the text book of Bioreaction 
Engineering Principles [44]. 
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Figure 4.1: Graphical illustration of the three mostly used fermentation systems: batch, fed-batch and chemostat.  
4.3. Experimental data 
During this work, several strains with plasmid-based modifications of the PHK-pathway and 
the EDP-pathway were grown in shake flasks in which, general physiological traits were 
monitored (paper II). In paper IV, different FAEE producing strains of S. cerevisiae were 
cultivated in controlled batch fermentation to characterize the physiological behavior and to 
sample for global transcriptional analysis.  
In paper II, the native pathway in S. cerevisiae towards cytosolic acetyl-CoA synthesis was 
metabolically engineered to increase the flux towards acetyl-CoA required for the formation 
of FAEEs. Ethanol, the second metabolite for synthesis of FAEEs, forms the major byproduct 
during FAEE production in S. cerevisiae. To re-channel the carbon flux towards the synthesis 
of acetyl-CoA, Adh2 and Ald6, which respectively catalyze the conversion of ethanol to 
acetaldehyde and acetaldehyde to acetate, were overexpressed together with the heterologous   
acsSEL641P, which encodes a de-regulated acetyl-CoA synthetase that catalyzes the conversion 
of acetate to acetyl-CoA. Also the introduction of the PHK pathway was thought to 
potentially increase the yield of FAEEs in S. cerevisiae due to its ability to generate two 
moles of NADPH per mole of glucose, which would provide additional NADPH for acyl-
CoA synthesis. Therefore, two genes, xpkA and ack, both descending from A. nidulans, were 
expressed to catalyze, respectively, the conversion of xylulose-5-phosphate to acetyl 
phosphate and glyceraldehyde-3-phosphate and acetyl phosphate to acetate with the gain of 
one ATP. A second strain was constructed, in which the gene pta from B. subtilis replaced 
ack. Pta converts acetyl phosphate directly to acetyl-CoA. Details about the metabolic 
pathways and the strain construction were shown in chapter 2 and chapter 3. 
 
Wild type S. cerevisiae is a fast growing and robust microorganism. However, the genetic 
modifications leading to improved FAEE production could have an impact on its physiology. 
Cell growth, glucose consumption as well as ethanol formation and consumption were 
therefore monitored during shake flask cultivations (Table 4.1 and Figure 4.2). The final 
biomass of the engineered strains was reduced compared to the reference strain (BdJref) and 
also the maximum specific growth rate (μmax) for both PHK pathway expressing strains and 
ethanol degradation pathway engineered strains showed a reduction of up to 40% (BdJ08). 
The main difference between the reference strain and engineered strains for increased ethanol 
degradation was a slower maximal consumption rate of ethanol (qethmax) for the modified 
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strains. Especially the strains overexpressing genes ADH2, ALD6, acsSEL641P and ws2 showed 
a reduced ethanol consumption rate of, respectively, 45% and 70% compared to the reference 
strain. It seemed unlikely that FAEEs are toxic to S. cerevisiae at the concentrations produced 
here. There was also no negative effect on cell growth when 1 g/l of myristic acid ethyl esters 
were added to the medium (data not shown). Therefore, the reduced ethanol consumption 
rates observed during the ethanol degradation pathway might most likely be explained by the 
rapid conversion of the ethanol to cytosolic acetyl-CoA which hence reduces the amount of 
ethanol that can be oxidized in the mitochondria. It is a presumable assumption that the 
metabolic changes were caused by the stress caused by overexpression of several genes. 
 
Table 4.1 Physiological characteristics of modified strains 
 
For paper IV, three different mutant strains of S. cerevisiae, which were engineered to 
produce FAEEs, were compared with each other and with a wild type yeast strain, 
auxotrophic CEN.PK113-7D. For characterization of the strains, biological triplicates were 
grown in controlled batch fermentation. As described in earlier chapters, strain BdJ12 carried 
overexpressed endogenous as well as heterologous genes ws2, ADH2, ALD6 and acsSEL641P, 
ACC1S1157A,S659A and ACB1 integrated into its chromosome [151]. The modifications were 
implemented to enable FAEE production and to ensure an efficient precursor supply. Strain 
BdJ15 additionally carried five different gene deletions to prevent the conversion of free fatty 
acids to sterol esters, triacylglycerides and their degradation to acetyl-CoA via the β-oxidation 
pathway (dga1Δ lro1Δ are1Δ are2Δ pox1Δ) [151]. The last FAEE producing strain, CB2I20, 
carried about six copies of the gene ws2, which were integrated into the chromosome [84]. 
See figure 3.8, 4.5 and table 2.1. The growth of all strains was followed until the stationary 
phase and the concentrations of glucose, ethanol, glycerol and acetate were measured during 
Strain 
(Over)expressed genes 
(HIS3 plasmid) & (URA3 
plasmid) 
Final 
FAEE 
yield  (μg 
gCDW-1) 
Maximal 
specific 
growth rate 
(μmax) (h-1) 
Final 
biomass 
(OD 
600) 
Glucose 
rate (qsmax)  
(h-1) 
Ethanol 
rate 
(qethmax) 
(h-1) 
BdJref --- & --- 16.3 ± 3.5 0.190 ± 0.010 
5.84 ± 
0.14 
-1.534 ± 
0.054 
-0.204 ± 
0.015 
Phosphoketolase pathway 
BdJ01 ws2 & --- 18 ± 4.8 0.159 ± 0.006 
5.51 ± 
0.16 
-1.448 ± 
0.057 
-0.200 ± 
0.021 
BdJ02 ws2 & xpkA, ack 28.0 ± 3.5 0.168 ± 0.009 
5.27 ± 
0.13 
-1.357 ± 
0.084 
-0.208 ± 
0.016 
BdJ03 ws2 & xpkA, pta 105 ± 30 0.136 ± 0.025 
4.55 ± 
0.11 
-1.357 ± 
0.078 
-0.197 ± 
0.014 
Ethanol degradation pathway 
BdJ07 --- & ws2 133 ± 113 0.192 ± 0.003 
5.14 ± 
0.22 
-1.403 ± 
0.035 
-0.174 ± 
0.003 
BdJ08 ws2, ALD6, ADH2, acsSEL641P & --- 408 ± 270 
0.115 ± 
0.026 
3.97 ± 
0.42 
-1.265 ± 
0.365 
-0.113 ± 
0.002 
BdJ09 ALD6, ADH2, acsSEL641P & ws2 359 ± 128 
0.136 ± 
0.035 
3.67 ± 
1.82 
-1.208 ± 
0.495 
-0.061 ± 
0.023 
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the same time period (Figure 4.3). The biological triplicates of each strain showed similar 
characteristics with small standard deviations for all values, the carbon balances are shown in 
table 4.2.   
 
Figure 4.2: Cell growth and substrate consumption of recombinant strains during shake flask cultivation. The 
strains BdJref and BdJ01-BdJ06 were analyzed in biological triplicates. The glucose concentration (g l-1) is 
indicated by squares, the ethanol concentration (g l-1) is indicated by triangles and cell growth (OD 600) is 
shown by diamonds. 
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Figure 4.3: Physiological parameters from biological triplicates (standard deviations) of strain CEN.PK113-7D 
(A), BdJ12 (B), BdJ15 (C) and CB2I20 (D) grown in controlled batch reactors. The red dots show the time point 
in which samples were taken for transcriptional analysis. 
 
It could be observed that glucose was completely consumed, resulting in maximal specific 
growth rates (μmax) which were reduced for the modified strains (table 4.2). While glucose 
was consumed and biomass was formed, three different byproducts were detected, ethanol, 
glycerol and acetate. Once glucose was consumed the diauxic shift occurred from glucose to 
ethanol consumption. It was eye catching that the growth rate of strain BdJ15 was much lower 
than the growth of the other strains on ethanol, which could also be seen in the much longer 
duration of the ethanol phase of that strain. While the reference strain accumulated the largest 
total amount of biomass (7.1 g l-1), it was closely followed by strains BdJ12 and CB2I20, 
whereas strain BdJ15 reached only about 4 g l-1 of final biomass (see figure 4.3). 
Table 4.2: Physiological parameters from biological triplicates of strain CEN.PK113-7D, BdJ12, BdJ15 and 
CB2I20 grown in controlled batch reactors.  
strain 
max. growth 
rate on 
glucose μ (h-1) 
max. growth 
rate on ethanol 
μeth (h-1) 
glucose uptake 
rate qg (h-1) 
ethanol uptake 
rate qeth (h-1) 
carbon 
balance 
CEN.PK113-7D 0.45 ± 0.01 0.39 ± 0.01 -1.77 ± 0.16 -0.89 ± 0.01 1.05 ± 0.00 
BdJ12 0.34 ± 0.01 0.24 ± 0.01 -0.56 ± 0.10 -0.46 ± 0.10 0.96 ± 0.05 
BdJ15 0.26 ± 0.00 0.06 ± 0.00 -1.03 ± 0.06 -0.36 ± 0.02 0.92 ± 0.02 
CB2I20 0.42 ± 0.04 0.27 ± 0.01 -1.17 ± 0.17 -0.78 ± 0.04 0.89 ± 0.01 
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Another clear difference between the four strains was the large accumulation of acetate during 
the glucose consumption phase of strain BdJ15. 2.5 g l-1 of acetate was accumulated during 
the BdJ15 batch culture, which was five times higher than the accumulation of acetate during 
cultivation of the other strains. Together with ethanol, acetate was co-consumed in all yeast 
strains (figure 4.4). 
The co-production of glycerol during production of ethanol in yeast is a consequence of redox 
balancing of the yeast cell. Here it could be observed that the reference strain (CEN.PK113-
7D) and strain BdJ12 accumulated about 0.3 g l-1 glycerol, which was completely consumed 
during growth on ethanol. These values differentiated from the glycerol accumulation in 
strain BdJ15, which was 2-fold higher (0.6 g l-1 and the glycerol accumulation in strain 
CB2I20, which was reduced (0.15 g l-1) (see figure 4.4). Another observation was the lack of 
glycerol consumption of BdJ15 and the lack of complete glycerol consumption of CB2I20. 
The difference of glycerol metabolism might indicate cellular stress or difficulties of 
maintaining the cellular redox balance. However, the latter argument could be excluded, 
because of a degree of reduction (κ) balance calculation, which indicated no significant redox 
imbalance [44].  
 
Figure 4.4: Acetate and glycerol concentration of reference and FAEEs producing mutant strains. 
From the physiological data from paper II it became clear that the introduction of the 
modifications slowed down the maximal specific growth rates of the different strains. 
Additionally, some of the strains showed some reduced ethanol consumption rate, which was 
possibly caused by stress. In paper IV the main physiological observation was the reduced 
ethanol consumption rate of strain BdJ15, in combination with a large acetate and glycerol 
production, which are most probably caused by the disruption of the acyl-CoA competing 
pathways. Also the growth rate was reduced due to the implementation of the modifications. 
It became clear that the data from the uncontrolled shake flasks cultivation and the data from 
the controlled batch fermentation are not comparable, which was inter alia due to the use of 
different media. 
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4.4. Quantification of FAEEs  
Accurate product detection and quantification is crucial for the evaluation of a cell factory. 
Additionally, the quantification needs to be performed with the same high-throughput manner 
as the other factors in the strain developing pipe-line. During this work, intracellular 
accumulation of FAEEs was measured with a gas chromatograph-mass spectrometer (GC-
MS) which could precisely detect the quantity of different (carbon-) chain length of FAEEs. 
Here, 12:0, 14:0, 16:0, 16:1, 18:0 and 18:1 were detected. Quantification was done using the 
addition of a known amount of internal standard of heptadecanoic acid ethyl ester (17:0) to 
the sample. However, the quantification of FAEEs is time consuming and far from high-
through-put practice. Sample preparation, in which it was challenging to exclude systematic 
errors, involved sample washing, freeze-drying, extracting of total lipids, separation of the 
lipids by thin liquid chromatography (TLC) and final collection of the FAEEs for the 
separation and quantification by GC-MS. A precise description was given in the material and 
methods section of paper II [164]. 
It is inevitable that the detection and evaluation of the product formation should be performed 
in a cleverer way. To keep the precision and accuracy of the product quantification, one might 
want to continue with the use of the GC-MS system for the detection of the FAEEs. However, 
the sampling to detection pipeline needs to be shortened. Solutions could be twofold: First, of 
all, the sample preparation pipeline could be shortened by the implementation of other 
techniques for the separation of FAEEs (as an example the use of head-space detection). A 
second option would be to establish extracellular detection of FAEEs, which would 
circumvent most of the time consuming extraction from the yeast cells during sample 
preparation. The use of a dodecane overlay during cultures might help the excretion of the 
product and in future larger amounts of product might stress the cell for excretion of the 
FAEEs. The detection and quantification of indirect indicators for FAEE, which are fast to 
analyze, would be another option. Examples could be a biosensor systems, which are often 
coupled to fast detection of fluorescence by flow cytometry [243]. However, the risk of 
indirect product detection is the loss of accuracy of the quantification. 
4.5. System wide profiling of cell factories 
System wide screening and therefore the use of -omics techniques became indispensable for 
the analytical evaluation of microbial cell factories. As described in chapter 1, different -
omics techniques can cover all cellular layers of the central dogma. These methods are 
especially valuable for understanding complex cellular systems and new phenotypes created 
by metabolic engineering. During this work, paper IV, global transcriptional profiling of 
three different S. cerevisiae mutants (strains BdJ12, BdJ15 and CB2I20) was performed with 
the help of microarray technology to find out new metabolic engineering strategies for the 
improvement of FAEE producing cell factories. Detailed description of the genetic changes of 
the strains can be found in chapter 3 while the physiological behavior was described above in 
this chapter. Specifically the expected transcriptional changes (p-value 0.01), due to the 
applied genetic modifications of all three strains were compared to reference strain 
CEN.PK113-7D, which was not able to produce FAEEs. In addition, the influence of the gene 
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deletions on the global transcriptional level was investigated by comparing differential 
expression of strains BdJ12 and BdJ15. 
It could be observed that genes ADH2 and ALD6 in BdJ12 and BdJ15 showed increased 
expression compared to the reference strain during glucose consumption. But despite the 
introduction of the extra copy, it could also be observed that ADH2 showed lower expression 
in BdJ15 than the reference strain during consumption of ethanol (figure 4.5). This finding 
was not expected although it is known that expression of the alcohol dehydrogenase is also 
strongly regulated by the carbon source on post-translational level [195], but possibly this 
resulted from a changed expression of the wild type gene copy in this strain. Acetyl-CoA 
synthase is catalyzing the conversion of acetate to acetyl-CoA, encoded by the combination of 
endogenous genes (ACS1 and ACS2) and the heterologously expressed acsSEL641P. As 
expected, expression of the heterologous gene did not lead to major expression changes in the 
endogenous genes, which may be partly due to the known regulation of the protein by 
acetylation [174].  
Cytosolic acyl-CoA formation is catalyzed by fatty acid synthase, encoded by genes FAS1 
and FAS2. The synthesis of these metabolites starts with loading acetyl-CoA to the acyl 
carrier protein (ACP) by ACP acyltransferase (AT) and is followed by repetitive elongation 
under consumption of malonyl-CoA [225]. Malonyl-CoA is formed from acetyl-CoA by 
acetyl-CoA carboxylase (reviewed by [214]). Here it was shown that both Endegenous acetyl-
CoA carboxylase encoded by gene ACC1, the heterologous overexpressed variant 
ACC1S1157A,S659A and fatty acid synthase (FAS1 and FAS2) were upregulated in all three 
engineered strains during glucose consumption. During the ethanol phase no significant 
change was detected despite the overexpression of the ACC1 variant in strains BdJ12 and 
BdJ15 (figure 4.5).  
In strain BdJ15, genes DGA1, LRO1, ARE1, ARE2 and POX1, which are involved in acyl-
CoA consuming pathways, were disrupted, which also became evident from the 
transcriptional analysis (figure 4.5). Genes DGA1, ARE1 and ARE2 were up-regulated during 
both glucose and ethanol phase, while gene LRO1 showed decreased expression during all 
measurements in both strains BdJ12 and CB2I20. β-oxidation pathway genes POX1, POT1 
and ECI1 in strains BdJ12 and CB2I20 were highly up-regulated during glucose phase while 
during ethanol phase, the β-oxidation pathway was down-regulated in strain CB2I20. An 
interesting observation was that genes FOX1, POT1 and ECI1 in strain BdJ15 were highly 
expressed, especially during ethanol phase, despite the POX1 deletion. 
ACB1 (coding for acyl-CoA binding protein) was up-regulated in all FAEE producing strains, 
but the fold change was higher in strains BdJ12 and BdJ15, in which the gene was actually 
overexpressed (figure 4.5). During growth on glucose the glycerol production pathway, 
encoded by four genes (GDP1, GDP2, GPP1 and GPP2), was down-regulated in all three 
engineered strains, but upregulated during growth on ethanol in strain BdJ12 and BdJ15. PP 
pathway genes GND2, SOL4 and TKL2 (and in lower amounts ZWF1) were up-regulated in 
strain BdJ12 during both glucose and ethanol phase. The same genes were more mitigated 
during growth on ethanol in strain BdJ15 and during the glucose phase in strain CB2I20. 
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4.5.1. GO-term analysis, reporter metabolites and consensus scoring of gene 
sets 
In strain BdJ15 additional carbon became available for the formation of FAEEs because of the 
disruption of metabolic pathways leading towards TAGs (dga1Δ lro1Δ), sterol esters (are1Δ 
are2Δ) and acetyl-CoA via the β-oxidation pathway (pox1Δ) [151]. Although the 
consequences of these modifications on the regulation of the global metabolism were unclear, 
with the observation of physiological changes of i.e. growth rate during ethanol consumption 
and acetate and glycerol accumulation, it became interesting to investigate the global 
transcriptional changes caused by the disruption of these genes. Therefore a ‘GO-term’, 
‘Reporter Metabolite’ analysis and consensus scoring of different gene sets were performed of 
the differentially transcribed genes of strains BdJ12 and BdJ15. 
Three major changes between strain BdJ12 and strain BdJ15 were observed during growth on 
glucose. First of all, transcriptional changes within major mitochondrial processes suggested 
oxidative stress and difficulties maintaining the demand of energy in the form of ATP via 
oxidative phosphorylation. Secondly, reporter metabolite analysis highlighted transcriptional 
changes around 6-phospho-D-gluconate (PPP, oxidative part, connected genes: SOL3, SOL4, 
GND1 and GND2) and sedoheptulose-7-phosphate (PPP, non-oxidative part, connected 
genes: TKL1, TKL2 and TAL1), which are possibly related to the provision of cofactor 
NADPH, required for reduction during fatty acid biosynthesis. Gene GRE2, which is involved 
in the oxidation of NADPH to NADP+, in general induced by stress [244, 245], was 
transcriptional down-regulated which could indicated a lack of NADPH or an increased stress 
level. This transcriptional change caused by cellular stress seemed to be in consensus with the 
physiological results. It was interesting that the complete ergosterol biosynthesis was down-
regulated in strain BdJ15 during glucose consumption. Important roles, i.a. a role in fluidity of 
lipid membranes and contribute to vital cellular processes like cellular sorting, the 
cytoskeleton organization or mating (reviewed by [246, 247]), but also play an important role 
in thermotolerance [248] are dedicated to the different sterols derived from the ergosterol 
pathway. It can be speculated that despite the down-regulation of the pathway, a sufficient 
supply of sterols for the vital cellular processes was provided. Earlier research also indicated 
that the ergosterol pathway was down-regulated under carbon limitation [249] and that the 
oxygen uptake rate was also related to the ergosterol pathway.  
Other transcriptional changes caused by the gene disruptions highlighted an increased 
expression of elongase (ELO1), which catalyzes the extension of unsaturated acyl-CoAs 
(carbon length 12-16) towards very long chain fatty acids and transcriptional activity of the 
genes connected to the metabolite octadecanoyl-CoA, an intermediate in the beta-oxidation 
pathway in the peroxisome. Both expressional changes could have a relation to the final chain 
length and saturation of the FAEEs.  
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4.6. Conclusion 
The above described characterized strains represent the largely modified S. cerevisiae cell 
factories designed for the production of FAEEs. From both, physiological and transcriptional 
results it became clear that the disruption of acyl-CoA competing pathways caused cellular 
stress, which influenced the cellular growth. Additionally, it could be seen that there was a 
demand for NADPH, required for reduction steps during fatty acid synthase and therefore 
alternative NADPH supplying strategies could be targeted. Future metabolic engineering 
strategies on genes which were known to be suppressed by cellular regulation might also want 
to address the regulatory mechanism of the genes. A sum of several engineering strategies 
will absolutely improve the productivity of FAEEs in future. 
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5. Conclusion and future perspectives 
Currently there is a need for sustainable solutions to replace fossil fuels, like diesel. One 
alternative are FAMEs, however, for several reasons the production method is not sustainable. 
A more sustainable production method is based on microbial cell factories. The aim of this 
PhD-thesis was the investigation and improvement of a FAEE producing microbial cell 
factory based on a S. cerevisiae host.  
5.1. Metabolic engineering strategies 
During this research, three metabolic engineering strategies improved the production of 
FAEEs in the S. cerevisiae host. The first strategy included the improvement of the native 
cytosolic pyruvate dehydrogenase bypass including the regulation of the acetaldehyde branch 
point and expression of a wax ester synthase which resulted in a 2.7 fold yield of FAEEs (see 
chapter 3.3 and paper II). A second metabolic engineering strategy was performed to re-
channel the carbon flux via the PP pathway and the heterologous PHK pathway towards 
acetate or acetyl-CoA and eventually to FAEEs. The expression of xpkA, pta and ws2 
debouched into a 5.7 fold improved of the FAEE yield (see chapter 3.4 and paper II). Many 
different metabolic engineering strategies have been employed individually to improve S. 
cerevisiae cell factories for fatty acid derived products. There against, in the third strategy, 
combined overexpression of ws2, ADH2, ALD6, acsSEL641P, ACC1S1157A,S659A and ACB1, which 
were stably integrated into the chromosome, was investigated together with the disruption of 
acyl-CoA competing pathways for the production of FAEEs (see chapter 3.5 and paper III). 
This resulted in a 4.1 fold improvement compared to sole ws2 expression. 
The above mentioned engineering strategies all demonstrated successful improvements in the 
yield of FAEEs in S. cerevisiae. However, despite this success, the final yields and titers of 
the engineered strains did not result in competitive values. The evaluation of the above 
strategies leads to a couple of essential future engineering targets to improve the production of 
FAEEs in S. cerevisiae. 
The first bottleneck faces the key-enzyme of this cell factory, the wax ester synthase. During 
this work the gene ws2 from M. hydrocarbonoclasticus was used because of its superior 
conversion of alcohols (including ethanol) and acyl-CoA into FAEEs, compared to other 
known enzymes. It was thought that the modest yield of FAEEs, despite the major 
engineering efforts (described above), was partly blamed by the conversion capacity of the 
wax ester synthase. Wax ester synthase engineering strategies could e.g. lead to improved 
substrate affinities. Strain BdJ15 represents a very good starting point for further engineering, 
e.g. evaluation of the effect of increased expression of the wax ester synthase. 
Another important engineering target is the improvement of the acyl-CoA biosynthesis in 
yeast. While acetyl-CoA carboxylase, acyl-CoA binding protein and fatty acid synthase [82] 
have been engineering targets before, the improvements were only limited. The enzymes are 
tightly regulated by several cellular layers and therefore improvement of this pathway will go 
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hand in hand with fundamental understanding of the regulatory mechanisms. For example, 
screening enzyme libraries from oleaginous organisms for homology might point out enzymes 
parts which are sensitive to regulation. 
The largest byproduct of the FAEE cell factory in S. cerevisiae is the natural product ethanol. 
Despite the overexpression of ADH2, which encodes the only alcohol dehydrogenase that 
converts ethanol into acetaldehyde, no reduction of ethanol was observed. Complete deletion 
of the alcohol dehydrogenase complex is not a suitable metabolic engineering strategy, 
because of the fact that ethanol is one of the substrates for FAEE. Production of other fatty 
acid derived products, i.e. fatty alcohols, is additionally, dependent on alcohol dehydrogenase 
activity. Therefore, a solution to remove ethanol to an extend that it is only available for 
product formation could be by the partial deletion or down-regulation of alcohol 
dehydrogenases involved in the formation of ethanol. Another, rather complicated, option 
could be an extensive engineering strategy including several heterologous pathways. While 
the cytosolic conversion of pyruvate to acetaldehyde (catalyzed by the pdc enzyme family) 
would be disrupted, several heterologous pathways, like the pyruvate dehydrogenase complex 
(PDH) from Enterococcus faecalis [176], the PFL pathway [177] and the PHK pathway [164] 
could lead towards the formation of acetyl-CoA and further conversion to acyl-CoA. 
Additional introduction of the A-ALD [177], naturally expressed in several prokaryotes, which 
catalyze the reversible reaction converting acetyl-CoA into acetaldehyde could regain the 
formation of ethanol. Circumventing endogenous pathways by the introduction of 
heterologous pathways, which often come with an advantage of cofactor or energy yield, has 
still many pitfalls, as for example the functionality of the heterologous enzymes in S. 
cerevisiae. 
 
Another metabolic engineering strategy for the improvement of FAEE production in S. 
cerevisiae might be the deletion of acetyl-CoA competing pathways, which has been used 
earlier by deletion of CIT2 and MLS1 [166]. The transcriptional analysis performed in paper 
IV suggested the additional demand of NADPH. As indicated earlier [198], the metabolic flux 
through the PHK pathway was only limited and therefore this pathway should become more 
attractive for metabolic flux. 
5.2. Pathway assembly and construction of microbial cell factories 
During this work, large effort was consumed by the construction of the metabolic pathway 
which had to be implemented into the S. cerevisiae host. In theory, all constructed strains 
could have been assembled within a many times shorter period. Unfortunately a large gap 
existed between the theoretical time of pathway assembly described by the individual 
methods (see chapter 2) and the practical attempts to assemble pathways by using different 
(cloning) techniques. It becomes clear that there is a high demand of high-throughput pathway 
assembly methods including criteria as efficiency, reliability, flexibility, time of assembly, 
fragment size, size of the total pathway, regulation and expression platform. As described 
before, a clear result from a comparative research [86] attributes the assembly advantage to 
ligase cycling reaction cloning and homologous recombination. In agreement with this study, 
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homologous recombination was used for successful pathway assembly and integration during 
this work (paper III). The success of pathway expression and consequently cellular 
phenotyping is also leaning on the expression platform and the pathway regulation (mostly 
dependent on different promoter types) provided. Chromosomal expression should be an 
integrative part of pathway engineering instead of the plasmid based expression to circumvent 
instability problems occurring with the implementation of larger pathways. Nevertheless, 
hopefully will the ongoing development of pathway assembly result in methods to evaluate 
the microbial phenotype much sooner in future.  
Considering the efforts described above, it was amusing but mostly interesting reading some 
very daring future perspectives on cell factory design of one of the professors acting in the 
forefront of the field of metabolic engineering [40]. Jay Keasling envisioned on a future with 
tailor made, synthetically designed chromosomes including biosynthetic pathways constructed 
from a parts registry containing all known enzymes to maximize yield and to minimize the 
time required to grow the organism, including a genetic control system controlling gene 
expression at the correct time and appropriate levels. Additionally, he would like to see the 
synthetic designed chromosomes implemented in customized cellular envelopes, designed to 
withstand industrial processes to produce the desired chemical compound from the desired 
starting material. The combination of skills from the fields of metabolic engineering and 
synthetic chemistry would enable these fully functional self-replicating cell factories to 
minimize the time required to grow and to maximize the product yield. While this idealistic 
view covers a more futuristic view, it can already been seen that first steps of a combined 
synthetic and biological pathway assembly methods are performed now-a-days in which part 
of the DNA sequence is chemically synthesized and others are ‘reused’ by cloning techniques. 
Here, I could imagine a slowly growing larger share for the synthetic and computational 
technologies and a continuing joined venture between the different expertises towards a 
similar view as described above. A recent work on synthesizing a minimized genome by the J. 
Craig Venter Institute (JCVI) might be another step towards above described future [250].  
 
A final comment on the pathway assembly paragraph is that despite the perspective of future 
cell factory engineering, current methods, using well known microorganisms with tractable 
genetic systems are highly relevant, and the development of pathway assembly methods, tools 
and fundamental knowledge for existing hosts, like S. cerevisiae, will enable the 
competitiveness of many microbial cell factories. 
5.3. Feasibility 
Transportation fuels, like FAEEs, have by far the highest volume and lowest economical 
margin of all metabolically engineered products. The economical feasibility of production of 
FAEEs will be dependent on availability of low-cost starting materials such as starch, sucrose, 
or cellulosic biomass. Apart from a cheap feedstock, the commercial success of FAEE 
production in yeast cell factories is dependent on the fatty acid derived products platform. 
Because of the high developing costs, it is important to strategically position the bulk 
biodiesel product within a platform of higher value compounds like for example 
60 
 
pharmaceuticals and flavors. The product portfolio of Amyris Inc is a good example for this. 
Another essential criterion for the production of transportation fuels is the product excretion 
from the microbes and the ease of recovery of the product. This is not only necessary to close 
the tight economical margin on bulk products, but also for fast and accurate quantification, 
needed for evaluation of newly designed cell factories. High through-put methods to analyze 
cell factory systems throughout the central dogma will therefore remain crucial to increase the 
speed and reduce the costs of the development of cell factories. 
All together, as long as there will be a transportation platform based on diesel engines, I am 
convinced that FAEEs, sustainably produced in a S. cerevisiae cell factory will become an 
economically competitive production method. Together, technological development, 
improved fundamental knowledge and commercial interest will push FAEEs, as part of the 
fatty acid derived products platform, towards a world of mobilization.  
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